Summit Healthcare REIT 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 07, 2022
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	000-52566
Entity Registrant Name	SUMMIT HEALTHCARE REIT, INC.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	73-1721791
Entity Address, Address Line One	23382 MILL CREEK DRIVE, SUITE 125,
Entity Address, City or Town	LAGUNA HILLS
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92653
City Area Code	800
Local Phone Number	978-8136
Title of 12(b) Security	N/A
Security Exchange Name	NONE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,027,978
Entity Central Index Key	0001310383
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
No Trading Symbol Flag	true

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 12,089,000	$ 10,488,000
Restricted cash	2,825,000	2,673,000
Real estate properties, net	174,683,000	179,102,000
Intangible lease assets, net	13,950,000	14,687,000
Tenant and other receivables, net	4,673,000	3,386,000
Deferred leasing commissions, net	402,000	466,000
Other assets, net	1,683,000	422,000
Equity-method investments	7,640,000	7,902,000
Total assets	217,945,000	219,126,000
LIABILITIES AND EQUITY
Accounts payable and accrued liabilities	6,001,000	2,551,000
Security deposits	4,651,000	4,651,000
Loans payable, net of debt issuance costs	180,223,000	180,370,000
Total liabilities	190,875,000	187,572,000
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding at September 30, 2022 and December 31, 2021
Common stock, $0.001 par value; 290,000,000 shares authorized; 23,027,978 shares issued and outstanding at September 30, 2022 and December 31, 2021	23,000	23,000
Additional paid-in capital	116,424,000	116,401,000
Accumulated deficit	(89,548,000)	(85,041,000)
Total stockholders' equity	26,899,000	31,383,000
Noncontrolling interests	171,000	171,000
Total equity	27,070,000	31,554,000
Total liabilities and equity	$ 217,945,000	$ 219,126,000

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED BALANCE SHEETS
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	290,000,000	290,000,000
Common stock, shares issued	23,027,978	23,027,978
Common stock, shares outstanding	23,027,978	23,027,978

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Total rental revenues	$ 5,416,000	$ 1,853,000	$ 16,392,000	$ 4,061,000
Resident fees and services	1,125,000		2,396,000
Asset management fees	165,000	165,000	495,000	789,000
Interest income from notes receivable		7,000		20,000
Total operating revenue	6,706,000	2,025,000	19,283,000	4,870,000
Expenses:
Property operating costs	846,000	264,000	2,385,000	694,000
Resident costs	1,281,000		2,474,000
General and administrative	1,280,000	933,000	3,460,000	3,426,000
Depreciation and amortization	1,813,000	524,000	5,498,000	1,316,000
Total operating expenses	5,220,000	1,721,000	13,817,000	5,436,000
Operating income (loss)	1,486,000	304,000	5,466,000	(566,000)
Loss from equity-method investees	(7,000)	191,000	(496,000)	(595,000)
Gain on sale of equity-method investment				3,515,000
Other income	43,000	5,000	206,000	17,000
Interest expense	(3,498,000)	(729,000)	(9,634,000)	(1,767,000)
Net (loss) income	(1,976,000)	(229,000)	(4,458,000)	604,000
Noncontrolling interests' share in net (income) loss	(12,000)	(18,000)	(49,000)	(58,000)
Net (loss) income applicable to common stockholders	$ (1,988,000)	$ (247,000)	$ (4,507,000)	$ 546,000
Basic:
Net (loss) income applicable to common stockholders	$ (0.09)	$ (0.01)	$ (0.20)	$ 0.02
Diluted:
Net (loss) income applicable to common stockholders	$ (0.09)	$ (0.01)	$ (0.20)	$ 0.02
Weighted average shares used to calculate earnings per common share
Basic	23,027,978	23,027,978	23,027,978	23,027,978
Diluted	23,027,978	23,027,978	23,027,978	23,553,606

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total Stockholders' Equity	Noncontrolling Interests	Total
Balance at the beginning at Dec. 31, 2020	$ 23,000	$ 116,335,000	$ (84,456,000)	$ 31,902,000	$ 195,000	$ 32,097,000
Balance at the beginning (in shares) at Dec. 31, 2020	23,027,978
Stock-based compensation	$ 0	36,000	0	36,000	0	36,000
Distributions paid to noncontrolling interests	0	0	0	0	(16,000)	(16,000)
Net (loss) income	0	0	(1,758,000)	(1,758,000)	18,000	(1,740,000)
Balance at the end at Mar. 31, 2021	$ 23,000	116,371,000	(86,214,000)	30,180,000	197,000	30,377,000
Balance at the end (in shares) at Mar. 31, 2021	23,027,978
Balance at the beginning at Dec. 31, 2020	$ 23,000	116,335,000	(84,456,000)	31,902,000	195,000	32,097,000
Balance at the beginning (in shares) at Dec. 31, 2020	23,027,978
Net (loss) income						604,000
Balance at the end at Sep. 30, 2021	$ 23,000	116,391,000	(83,910,000)	32,504,000	201,000	32,705,000
Balance at the end (in shares) at Sep. 30, 2021	23,027,978
Balance at the beginning at Mar. 31, 2021	$ 23,000	116,371,000	(86,214,000)	30,180,000	197,000	30,377,000
Balance at the beginning (in shares) at Mar. 31, 2021	23,027,978
Stock-based compensation	$ 0	11,000	0	11,000	0	11,000
Distributions paid to noncontrolling interests	0	0	0	0	(19,000)	(19,000)
Net (loss) income	0	0	2,551,000	2,551,000	22,000	2,573,000
Balance at the end at Jun. 30, 2021	$ 23,000	116,382,000	(83,663,000)	32,742,000	200,000	32,942,000
Balance at the end (in shares) at Jun. 30, 2021	23,027,978
Stock-based compensation	$ 0	9,000	0	9,000	0	9,000
Distributions paid to noncontrolling interests	0	0	0	0	(17,000)	(17,000)
Net (loss) income	0	0	(247,000)	(247,000)	18,000	(229,000)
Balance at the end at Sep. 30, 2021	$ 23,000	116,391,000	(83,910,000)	32,504,000	201,000	32,705,000
Balance at the end (in shares) at Sep. 30, 2021	23,027,978
Balance at the beginning at Dec. 31, 2021	$ 23,000	116,401,000	(85,041,000)	31,383,000	171,000	31,554,000
Balance at the beginning (in shares) at Dec. 31, 2021	23,027,978
Stock-based compensation	$ 0	8,000	0	8,000	0	8,000
Distributions paid to noncontrolling interests	0	0	0	0	(18,000)	(18,000)
Net (loss) income	0	0	(325,000)	(325,000)	19,000	(306,000)
Balance at the end at Mar. 31, 2022	$ 23,000	116,409,000	(85,366,000)	31,066,000	172,000	31,238,000
Balance at the end (in shares) at Mar. 31, 2022	23,027,978
Balance at the beginning at Dec. 31, 2021	$ 23,000	116,401,000	(85,041,000)	31,383,000	171,000	31,554,000
Balance at the beginning (in shares) at Dec. 31, 2021	23,027,978
Net (loss) income						(4,458,000)
Balance at the end at Sep. 30, 2022	$ 23,000	116,424,000	(89,548,000)	26,899,000	171,000	27,070,000
Balance at the end (in shares) at Sep. 30, 2022	23,027,978
Balance at the beginning at Mar. 31, 2022	$ 23,000	116,409,000	(85,366,000)	31,066,000	172,000	31,238,000
Balance at the beginning (in shares) at Mar. 31, 2022	23,027,978
Stock-based compensation	$ 0	6,000	0	6,000	0	6,000
Distributions paid to noncontrolling interests	0	0	0	0	(18,000)	(18,000)
Net (loss) income	0	0	(2,194,000)	(2,194,000)	18,000	(2,176,000)
Balance at the end at Jun. 30, 2022	$ 23,000	116,415,000	(87,560,000)	28,878,000	172,000	29,050,000
Balance at the end (in shares) at Jun. 30, 2022	23,027,978
Stock-based compensation	$ 0	9,000	0	9,000	0	9,000
Distributions paid to noncontrolling interests	0	0	0	0	(13,000)	(13,000)
Net (loss) income	0	0	(1,988,000)	(1,988,000)	12,000	(1,976,000)
Balance at the end at Sep. 30, 2022	$ 23,000	$ 116,424,000	$ (89,548,000)	$ 26,899,000	$ 171,000	$ 27,070,000
Balance at the end (in shares) at Sep. 30, 2022	23,027,978

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net (loss) income	$ (4,458,000)	$ 604,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Amortization of debt issuance costs	684,000	72,000
Depreciation and amortization	5,498,000	1,316,000
Amortization of above-market lease intangible	47,000	16,000
Straight-line rents	(1,108,000)	435,000
Stock-based compensation expense	23,000	56,000
Gain on sale of equity-method investment		(3,515,000)
Loss from equity-method investees	496,000	595,000
Change in operating assets and liabilities:
Tenant and other receivables, net	274,000	634,000
Other assets	(98,000)	561,000
Accounts payable and accrued liabilities	2,620,000	436,000
Security deposits		594,000
Net cash provided by operating activities	3,978,000	1,804,000
Cash flows from investing activities:
Real estate acquisitions		(20,133,000)
Additions to real estate and other assets	(483,000)
Investment in equity-method investees	(1,111,000)	(140,000)
Proceeds from sale of equity-method investment		5,411,000
Distributions received from equity-method investees	422,000	1,339,000
Payments from notes receivable		196,000
Net cash used in investing activities	(1,172,000)	(13,327,000)
Cash flows from financing activities:
Proceeds from issuance of loans payable		15,000,000
Payments of loans payable	(831,000)	(789,000)
Distributions paid to noncontrolling interests	(49,000)	(52,000)
Deferred financing costs	(173,000)	(228,000)
Net cash (used in) provided by financing activities	(1,053,000)	13,931,000
Net increase in cash, cash equivalents and restricted cash	1,753,000	2,408,000
Cash, cash equivalents and restricted cash - beginning of period	13,161,000	17,591,000
Cash, cash equivalents and restricted cash - end of period	14,914,000	19,999,000
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 7,864,000	$ 1,382,000

Organization

Organization	9 Months Ended
	Sep. 30, 2022
Organization
Organization	1. Organization Summit Healthcare REIT, Inc. (“Summit”) is a real estate investment trust that owns 100% of 14 properties, 95.3% of four properties, a 10% equity interest in an unconsolidated equity-method investment that holds 17 properties, a 35% equity interest in an unconsolidated equity-method investment that holds one property, a 20% equity interest in an unconsolidated equity-method investment that holds two properties, a 10% equity interest in an unconsolidated equity-method investment that holds nine properties, a 10% equity interest in an unconsolidated equity-method investment that holds six properties. In June 2021, we sold our 15% equity interest in an unconsolidated equity-method investment that held 14 properties. Summit is a Maryland corporation, formed in 2004 under the General Corporation Law of Maryland for the purpose of investing in and owning real estate. As used in these notes, the “Company”, “we”, “us” and “our” refer to Summit and its consolidated subsidiaries, including but not limited to Summit Healthcare Operating Partnership, L.P. (the “Operating Partnership”), except where the context otherwise requires. We conduct substantially all of our operations through the Operating Partnership, which is a Delaware limited partnership. We own a 99.88% general partner interest in the Operating Partnership, and Cornerstone Realty Advisors, LLC (“CRA”), a former affiliate, owns a 0.12% limited partnership interest. Summit and the Operating Partnership are managed and operated as one entity, and Summit has no significant assets other than its investment in the Operating Partnership. Summit, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership. Cornerstone Healthcare Partners LLC – Consolidated Joint Venture We own 95% of Cornerstone Healthcare Partners LLC (“CHP LLC”), which was formed in 2012, and the remaining 5% noncontrolling interest is owned by Cornerstone Healthcare Real Estate Fund, Inc. (“CHREF”), an affiliate of CRA. CHP LLC is consolidated within our condensed consolidated financial statements and owns four properties (the “JV Properties”) with another partially owned subsidiary. As of September 30, 2022 and December 31, 2021, we own a 95.3% interest in the four JV Properties, and CHREF owns a 4.7% interest. Summit Union Life Holdings, LLC – Equity-Method Investment In April 2015, through our Operating Partnership, we entered into a limited liability company agreement with Best Years, LLC (“Best Years”), an unrelated entity and a U.S.-based affiliate of Union Life Insurance Co, Ltd. (a Chinese corporation), and formed Summit Union Life Holdings, LLC (the “SUL JV”). The SUL JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of September 30, 2022 and December 31, 2021, we have a 10% interest in the SUL JV which owns 17 properties. Summit Fantasia Holdings, LLC – Equity-Method Investment In September 2016, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia Investment III LLC (“Fantasia”), an unrelated entity and a U.S.-based affiliate of Fantasia Holdings Group Co., Limited (a Chinese corporation listed on the Stock Exchange of Hong Kong (HKEX)), and formed Summit Fantasia Holdings, LLC (the “Fantasia JV”). The Fantasia JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of September 30, 2022 and December 31, 2021, we have a 35% interest in the Fantasia JV which owns one property at September 30, 2022 and owned two properties at December 31, 2021. Summit Fantasia Holdings II, LLC – Equity-Method Investment In December 2016, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia, and formed Summit Fantasia Holdings II, LLC (the “Fantasia II JV”). The Fantasia II JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of September 30, 2022 and December 31, 2021, we have a 20% interest in the Fantasia II JV which owns two properties. Summit Fantasia Holdings III, LLC– Equity-Method Investment In July 2017, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia and formed Summit Fantasia Holdings III, LLC (the “Fantasia III JV”). The Fantasia III JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of September 30, 2022 and December 31, 2021, we have a 10% interest in the Fantasia III JV which owns nine properties. Summit Fantasy Pearl Holdings, LLC– Equity-Method Investment In October 2017, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia, Atlantis Senior Living 9, LLC, a Delaware limited liability company (“Atlantis”), and Fantasy Pearl LLC, a Delaware limited liability company (“Fantasy”), and formed Summit Fantasy Pearl Holdings, LLC (the “FPH JV”). The FPH JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of September 30, 2022 and December 31, 2021, we have a 10% interest in the FPH JV which owns six properties. Indiana JV– Equity-Method Investment In June 2021, we sold our 15% equity interest in the Indiana joint venture (the “Indiana JV”) for approximately $5.4 million. See Note 5 for further information. As of September 30, 2022 and December 31, 2021, we have a 0% interest in the Indiana JV. Summit Healthcare Asset Management, LLC (TRS) Summit Healthcare Asset Management, LLC (“SAM TRS”) is our wholly-owned taxable REIT subsidiary (“TRS”). We serve as the manager of the SUL JV, Fantasia JV, Fantasia II JV, Fantasia III JV, and FPH JV, and the Indiana JV prior to the sale of our equity interest on June 11, 2021 (collectively, our “Equity-Method Investments”), and provide management services in exchange for fees and reimbursements. All asset management fees earned by us are paid to SAM TRS and expenses incurred by us, as the manager, are reimbursed from SAM TRS. See Notes 5 and 7 for further information.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies For more information regarding our significant accounting policies and estimates, please refer to “Summary of Significant Accounting Policies” contained in the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 31, 2022. In addition, refer to our revenue recognition note below related to our resident fees and services. The accompanying condensed consolidated balance sheet at December 31, 2021 has been derived from the audited consolidated financial statements at that date. We assume that users of these condensed consolidated financial statements have read or have access to the audited December 31, 2021 consolidated financial statements and contained in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 31, 2022 and that the adequacy of additional disclosure needed for a fair presentation, except in regard to material contingencies, may be determined in that context. Accordingly, footnotes and other disclosures which would substantially duplicate those contained in our most recent Annual Report on Form 10-K for the year ended December 31, 2021 have been omitted in this report. Principles of Consolidation and Basis of Presentation The accompanying condensed consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries, the Operating Partnership and its consolidated companies and are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). All intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial information reflects all adjustments, which are, in the opinion of management, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. Restricted Cash The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown on the condensed consolidated statements of cash flows. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Cash and cash equivalents ​ $ 12,089,000 ​ $ 10,488,000 Restricted cash ​ 2,825,000 ​ 2,673,000 Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows ​ $ 14,914,000 ​ $ 13,161,000 ​ Coronavirus (COVID-19) The world was, and continues to be, impacted by the COVID-19 pandemic. The healthcare industry was among those most adversely affected by the COVID-19 pandemic. Two of our tenants have experienced a material adverse effect on their operations related to COVID-19, which has affected their ability to make rent payments in 2022 and 2021 (see Note 3 for further information on its impact on us). The extent to which COVID-19 could continue to impact our business, cash flow and results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence. The fluidity of this situation precludes any prediction as to the ultimate material adverse impact on the demand for senior housing and skilled nursing and presents material uncertainty and risk with respect to our business, operations, financial condition and liquidity, including recording impairments, lease modifications and credit losses in future periods. Reclassification of Intangible Lease Assets The following table provides a reconciliation for the reclassification of our intangible lease assets as of December 31, 2021 in our consolidated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As previously reported Increase (decrease) As reclassified Real estate properties, net ​ $ 192,862,000 ​ $ (13,760,000) ​ $ 179,102,000 Intangible lease assets, net ​ $ — ​ $ 14,687,000 ​ $ 14,687,000 Other assets, net ​ $ 1,349,000 ​ $ (927,000) ​ $ 422,000 Total assets ​ $ 219,126,000 ​ $ — ​ $ 219,126,000 ​ The intangible lease assets related to our prior acquisitions in 2021 were reclassified from real estate properties, net and other assets, net into a separate line item as of September 30, 2022. The result of this reclassification did not have any effect on our total assets, liabilities, accumulated deficit, net loss or statements of cash flows. Revenue Recognition - Resident Fees and Services We recognize resident fees and services revenue at the amount that we expect to be entitled to in exchange for providing resident care and services. Resident fees are recognized and billed monthly based on the contracted rate in the resident lease agreements and the reimbursements from Medicaid are based on contracted reimbursement rates. These amounts are paid directly from the residents and/or third-party payors (currently only Medicaid). Revenue is recognized as performance obligations are satisfied. Performance obligations are determined based on the nature of the services provided by us. The majority of resident fees and services is attributable to the portion of the base monthly lease fee in the resident lease agreement. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes the resident fee revenue based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the lease component is the predominant component and the services included under the resident agreements have the same timing and pattern of transfer and are performance obligations that are satisfied over time. Resident services consist of care level services and certain other ancillary services (i.e., housekeeping, laundry, etc.). These services are provided and paid for in addition to the standard fees included in each resident lease (i.e., room and board, standard meals, etc.). Settlements with third-party payors for retroactive adjustments due to audits, reviews or investigations are considered variable consideration and are included in the determination of the estimated transaction price for providing patient care. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and our historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known (that is, new information becomes available), or as years are settled or are no longer subject to such audits, reviews and investigation.

Investments in Real Estate Prop

Investments in Real Estate Properties	9 Months Ended
	Sep. 30, 2022
Investments in Real Estate Properties
Investments in Real Estate Properties	3. Investments in Real Estate Properties As of September 30, 2022 and December 31, 2021, our investments in real estate properties including those held by our consolidated subsidiaries (excluding the 35 properties owned by our unconsolidated Equity-Method Investments) are set forth below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Land ​ $ 15,565,000 ​ $ 15,565,000 Buildings and improvements ​ 166,989,000 ​ 166,989,000 Less: accumulated depreciation ​ (14,840,000) ​ (11,395,000) Buildings and improvements, net ​ 152,149,000 ​ 155,594,000 Furniture and fixtures ​ 12,440,000 ​ 12,137,000 Less: accumulated depreciation ​ (5,471,000) ​ (4,194,000) Furniture and fixtures, net ​ 6,969,000 ​ 7,943,000 Real estate properties, net ​ $ 174,683,000 ​ $ 179,102,000 ​ For the three months ended September 30, 2022 and 2021, depreciation and amortization expense (excluding intangible lease amortization and leasing commission amortization) was approximately $1.6 million and $0.5 million, respectively. For the nine months ended September 30, 2022 and 2021, depreciation expense (excluding intangible lease amortization and leasing commission amortization) was approximately $4.8 million and $1.3 million, respectively. As of September 30, 2022, our portfolio consisted of 18 real estate properties, 16 of which were 100% leased to the tenants of the related facilities. The other two properties are each 100% leased to an affiliated subsidiary (see below under Pennington Gardens Operations LLC and Sundial Operations LLC). During 2021, our tenants for the Pennington Gardens and Sundial Assisted Living facilities experienced a material adverse effect on their operations related to COVID-19 and other operator issues that affected their ability to make their rent payments in 2022 and 2021. As a result, we experienced the following impacts: Pennington Gardens Operations LLC In March 2021, under a receivership, we began recording rent payments on a cash basis for our Pennington Gardens facility and wrote off the remaining straight-line rent receivable of $0.4 million. In October 2021, we reached an agreement with the tenant to terminate the lease. We notified the lender and the U.S. Department of Housing and Urban Development (“HUD”) and requested emergency approval to change the operator and terminate the lease. In November 2022, the operator change was approved by HUD. On February 3, 2022, the current receiver, who was acting as the operator, received the license to be the licensed operator. As such, on February 10, 2022, the tenant’s lease was terminated, and we received $0.2 million from the tenant as part of the settlement agreement which was recorded in total rental revenues in the condensed consolidated statements of operations for the nine months ended September 30, 2022. Concurrently, we entered into a new lease agreement with Pennington Gardens Operations LLC, the newly formed operating company for Pennington Gardens, which is a wholly owned subsidiary of SHOP TRS LLC, a wholly-owned taxable REIT subsidiary of Summit. As such, the operations of Pennington Gardens are consolidated in our financial statements beginning February 11, 2022, and all intercompany transactions have been eliminated. For the three and nine months ended September 30, 2022, revenues from Pennington Gardens Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations. Sundial Operations LLC In October 2021, we reached an agreement with the tenant of our Sundial Assisted Living facility in Redding, California to terminate the lease, and we requested approval from HUD to terminate the lease and install a new licensed operator/manager. Beginning in June 2021, we recorded rent payments on a cash basis and in May 2021, wrote off the remaining straight-line rent receivable of $0.1 million. On June 6, 2022, the new operator received approval to be the licensed operator of the facility and the previous tenant’s lease was terminated. We received $0.05 million from the tenant as part of the settlement agreement, which was recorded in total rental revenues in the condensed consolidated statements of operations for the nine months ended September 30, 2022. On June 7, 2022, we entered into a new lease agreement with Sundial Operations LLC, the newly formed operating company for Sundial Assisted Living, which is a wholly owned subsidiary of SHOP TRS LLC. As such, the operations of Sundial Assisted Living will be consolidated in our financial statements as of June 7, 2022. For the three and nine months ended September 30, 2022, revenues from Sundial Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations. The following table provides summary information regarding our portfolio (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the $12.75 million loan from Oxford Finance, LLC (“Oxford”) (see Note 4) with Summit Georgia Holdings LLC, our wholly-owned subsidiary) as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Payable, ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Excluding ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Debt ​ ​ ​ ​ ​ ​ ​ ​ Purchase ​ Issuance Property Location Date Purchased Type (1) Price Costs Sheridan Care Center Sheridan, OR ​ August 3, 2012 SNF ​ $ 4,100,000 ​ $ 4,044,000 Fernhill Care Center Portland, OR ​ August 3, 2012 SNF ​ 4,500,000 ​ 3,548,000 Friendship Haven Healthcare and Rehabilitation Center Galveston County, TX ​ September 14, 2012 SNF ​ 15,000,000 ​ 11,381,000 Pacific Health and Rehabilitation Center Tigard, OR ​ December 24, 2012 SNF ​ 8,140,000 ​ 5,915,000 Brookstone of Aledo Aledo, IL ​ July 2, 2013 AL ​ 8,625,000 ​ 6,633,000 Sundial Assisted Living (2) Redding, CA ​ December 18, 2013 AL ​ 3,500,000 ​ 3,698,000 Pennington Gardens (2) Chandler, AZ ​ July 17, 2017 AL/MC ​ 13,400,000 ​ 10,078,000 Yucaipa Hill Post Acute ​ Yucaipa, CA ​ July 2, 2021 ​ SNF ​ ​ 10,715,000 ​ ​ 8,014,000 Creekside Post Acute ​ Yucaipa, CA ​ July 2, 2021 ​ SNF ​ ​ 4,780,000 ​ ​ 3,575,000 University Post Acute ​ Mentone, CA ​ July 2, 2021 ​ SNF ​ ​ 4,560,000 ​ ​ 3,411,000 Calhoun Health Center ​ Calhoun, GA ​ December 30, 2021 ​ SNF ​ ​ 7,670,000 ​ ​ 6,549,000 Maple Ridge Health Care Center ​ Cartersville, GA ​ December 30, 2021 ​ SNF ​ ​ 13,548,000 ​ ​ 11,568,000 Chatsworth Health Care Center ​ Chatsworth, GA ​ December 30, 2021 ​ SNF ​ ​ 29,785,000 ​ ​ 25,432,000 East Lake Arbor ​ Decatur, GA ​ December 30, 2021 ​ SNF ​ ​ 15,640,000 ​ ​ 13,354,000 Fairburn Health Care Center ​ Fairburn, GA ​ December 30, 2021 ​ SNF ​ ​ 14,644,000 ​ ​ 12,503,000 Grandview Health Care Center ​ Jasper, GA ​ December 30, 2021 ​ SNF ​ ​ 10,061,000 ​ ​ 8,591,000 Rosemont at Stone Mountain ​ Stone Mountain, GA ​ December 30, 2021 ​ SNF ​ ​ 23,908,000 ​ ​ 20,414,000 Willowwood Nursing Center & Rehab ​ Flowery Branch, GA ​ December 30, 2021 ​ SNF ​ ​ 14,744,000 ​ ​ 12,589,000 Total: ​ ​ ​ ​ ​ ​ $ 207,320,000 ​ $ 171,297,000 (1) SNF is an abbreviation for skilled nursing facility. AL is an abbreviation for assisted living facility. MC is an abbreviation for memory care facility. (2) See above under Pennington Gardens Operations LLC and Sundial Operations LLC. Future Minimum Lease Payments The future minimum lease payments to be received under our existing tenant operating leases (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the intercompany leases between our wholly-owned subsidiaries, Summit Chandler LLC, Pennington Gardens Operations LLC, HP Redding LLC and Sundial Operations LLC) as of September 30, 2022, for the period from October 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows: ​ ​ ​ ​ ​ Years ending ​ ​ October 1, 2022 to December 31, 2022 ​ $ 4,433,000 2023 ​ 17,983,000 2024 ​ 18,272,000 2025 ​ 18,566,000 2026 ​ 18,865,000 Thereafter ​ 165,462,000 ​ ​ $ 243,581,000 ​ 2022 Acquisitions None . 2021 Acquisitions CA3 Properties On July 2, 2021, through our wholly-owned subsidiary, we acquired three skilled nursing facilities, two located in Yucaipa, California and one located in Mentone, California (collectively, the “CA3 Properties”), for the purchase price of $20,055,000, which was funded through cash on hand plus the proceeds from the loan described in Note 4. We incurred approximately $80,000 in acquisition costs in connection with these acquisitions. The CA3 Properties are leased to three tenants under three separate 15-year triple net leases, each of which has GA8 Properties On December 30, 2021, through Summit Georgia Holdings LLC, our wholly-owned subsidiary, we acquired eight skilled nursing facilities located in Georgia (collectively, the “GA8 Properties”), for the total purchase price of $130,000,000 , which was funded through cash on hand plus the proceeds from the loans described in Note 4. The GA8 Properties are leased to eight tenants under eight separate 15-year triple net leases, each of which has two five-year renewal options. Leasing Commissions As a self-managed REIT, we have not paid leasing commissions since 2013. Leasing commissions are capitalized at cost and amortized on a straight-line basis over the related lease term. As of September 30, 2022 and December 31, 2021, the unamortized balance of capitalized leasing commissions was approximately $0.4 million and $0.5 million, respectively. Amortization expense for the three months ended September 30, 2022 and 2021 was approximately $15,000 and $18,000, respectively. Amortization expense for the nine months ended September 30, 2022 and 2021 was approximately $63,000 and $53,000, respectively.

Loans Payable

Loans Payable	9 Months Ended
	Sep. 30, 2022
Loans Payable
Loans Payable	4. Loans Payable As of September 30, 2022 and December 31, 2021, our loans payable consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2022 December 31, 2021 Loans payable to Lument (formerly ORIX Real Estate Capital, LLC) (insured by HUD) in monthly installments of approximately $183,000, including interest, ranging from a fixed rate of 2.79% to 4.2%, due in September 2039 through April 2055, and as of September 30, 2022 and December 31, 2021, collateralized by Sheridan, Fernhill, Pacific Health, Aledo, Sundial and Friendship Haven. ​ $ 35,219,000 ​ $ 35,934,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to Capital One Multifamily Finance, LLC (insured by HUD) in monthly installments of approximately $49,000, including interest at a fixed rate of 4.23%, due in September 2053, and collateralized by Pennington Gardens. ​ ​ 10,078,000 ​ ​ 10,194,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to CIBC Bank, USA in monthly installments of approximately of $106,000 including cash collateral fund payments, variable interest rate as noted below (6.63% and 5% at September 30, 2022 and December 31, 2021, respectively), due in July 2024, and as of December 31, 2021, collateralized by Yucaipa Hill Post Acute, Creekside Post Acute and University Post Acute. ​ ​ 15,000,000 ​ ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to CIBC Bank, USA in monthly installments of approximately $459,000 (interest only through December 2023) variable interest rate as noted below (6.1% and 4% at September 30, 2022 and December 31, 2021, respectively), due in December 2024, and as of September 30, 2022 and December 31, 2021, collateralized by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab. ​ ​ 91,000,000 ​ ​ 91,000,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to Oxford Finance, LLC in monthly installments of approximately $226,000 (interest only through maturity), variable interest rate as noted below (13.6% and 12% at September 30, 2022 and December 31, 2021, respectively) due in March 2025, collateralized in second position by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab. ​ ​ 20,000,000 ​ ​ 20,000,000 ​ ​ ​ ​ ​ ​ ​ Mezzanine Loan payable to Oxford Finance, LLC in monthly installments of approximately $144,000 (interest only through maturity), variable interest rate as noted below (13.6% and 12% at September 30, 2022 and December 31, 2021, respectively) due in December 2026, secured by the equity interests of our wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties. ​ ​ 12,750,000 ​ ​ 12,750,000 ​ ​ 184,047,000 ​ 184,878,000 Less debt issuance costs ​ (3,824,000) ​ (4,508,000) Total loans payable ​ $ 180,223,000 ​ $ 180,370,000 ​ As of September 30, 2022, we have total debt obligations of approximately $184.0 million that will mature between 2024 and 2055. See Note 3 for loans payable balance for each property. All of the loans payable have certain financial and non-financial covenants, including ratios and financial statement considerations. As of September 30, 2022, we were in compliance with all of our debt covenants. During the three months ended September 30, 2022 and 2021, we incurred approximately $3.2 million and $0.7 million of interest expense, respectively (excluding debt issuance costs amortization and interest expense related to the Oxford mezzanine loan as noted below (“Oxford Monthly Fee”)), related to our loans payable. During the nine months ended September 30, 2022 and 2021, we incurred approximately $8.4 million and $1.7 million, respectively, of interest expense (excluding debt issuance costs and amortization and interest expense related to the Oxford mezzanine loan as noted below (“Oxford Monthly Fee”)) related to our loans payable. In connection with our loans payable, we incurred debt issuance costs. As of September 30, 2022 and December 31, 2021, the unamortized balance of the debt issuance costs was approximately $3.8 million and $4.5 million, respectively. These debt issuance costs are being amortized over the life of their respective financing agreements using the straight-line basis which approximates the effective interest rate method. For the three months ended September 30, 2022 and 2021, $0.2 million and $0.01 million, respectively, of debt issuance costs were amortized and included in interest expense in our condensed consolidated statements of operations. For the nine months ended September 30, 2022 and 2021, $0.7 million and $0.01 million, respectively, of debt issuance costs were amortized and included in interest expense in our condensed consolidated statements of operations. During the three months ended September 30, 2022, we incurred approximately $0.1 million of interest expense related to the Oxford Monthly Fee, which is included in interest expense in our condensed consolidated statements of operations. During the nine months ended September 30, 2022, we incurred approximately $0.5 million of interest expense related to the Oxford Monthly Fee and is included in interest expense in our condensed consolidated statements of operations. The principal payments due on the loans payable (excluding debt issuance costs and cash collateral funds) for the period from October 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows: ​ ​ ​ ​ ​ ​ ​ Principal Years Ending Amount October 1, 2022 to December 31, 2022 ​ $ 283,000 2023 ​ 1,158,000 2024 ​ 107,201,000 2025 ​ 21,246,000 2026 ​ 14,042,000 Thereafter ​ 40,117,000 ​ ​ $ 184,047,000 ​ The following information notes our 2021 loan activity: CA3 Properties On July 2, 2021, in conjunction with the acquisition of the CA3 Properties (see Note 3), we entered into a first priority $15.0 million mortgage loan collateralized by the CA3 Properties with CIBC Bank, USA (“CIBC”). The loan bears interest at the One Month London Interbank Offer Rate (“LIBOR”) (with a floor of 1%) plus 4.00%, or the Secured Overnight Financing Rate (“SOFR”) when LIBOR is discontinued, and matures on July 2, 2024. The loan is interest only for the first year and thereafter requires additional monthly installments of principal that are held by the lender in a cash loan guarantee fund until maturity. The loan may be prepaid at any time with no penalty if the CA3 Properties are refinanced through HUD, otherwise we would be required to pay a prepayment premium equal to three percent (3%), two percent (2%) and one percent (1%) of the amount of the outstanding principal balance of the Loan prepaid if such prepayment occurs on or prior to the first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively. In the event the Company sells or transfers one or more properties, we would be required to pay an exit fee equal to (i) one-half of one percent (0.5%) of the amount of the outstanding principal balance of the Loan if such sale or transfer occurs on or prior to the second (2nd) year anniversary of the Closing Date; and (ii) zero percent (0%) if such sale or transfer occurs after the second (2nd) year anniversary of the Closing Date. GA8 Properties We acquired our interest in the GA8 Properties subject to a $91.0 million first priority mortgage loan collateralized by those properties, a $20 million subordinated term loan collateralized by those properties and a $12.75 million mezzanine loan secured by the equity interests of the wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties. On December 30, 2021, we entered into a loan agreement with CIBC for $91.0 million in principal amount. The loan bears interest at the SOFR plus 3.50% with a SOFR floor of 50 basis points, or the bank’s base rate plus 0.75% (with a minimum of 4.0%), and matures on December 30, 2024. The loan is interest-only for two years and then requires additional monthly installments of principal that are held by the lender in a cash loan guarantee fund until maturity. The loan may be prepaid at any time with no penalty if the GA8 Properties are refinanced through HUD, otherwise we would be required to pay an a prepayment premium equal to three percent (3%), two percent (2%) and one percent (1%) of the amount of the outstanding principal balance of the Loan prepaid if such prepayment occurs on or prior to the first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively. In the event the Company sells or transfers one or more of the GA8 Properties, we would be required to pay an exit fee equal to (i) one-half of one percent (0.5%) of the amount of the outstanding principal balance of the Loan if such sale or transfer occurs on or prior to the second (2nd) year anniversary of the Closing Date; and (ii) zero percent (0%) if such sale or transfer occurs after the second (2nd) year anniversary of the Closing Date. On December 30, 2021, we entered into a subordinated term loan agreement with Oxford for $20.0 million in principal amount. The loan bears interest at LIBOR plus 11.0% with a LIBOR floor of 100 basis points (or with a LIBOR replacement rate), and matures on September 30, 2025. The loan is interest only. The entire loan may be prepaid at any time and would be subject at that time to a prepayment premium fee equal to five percent (5%), two percent (2%) and one percent (1%) of the amount repaid if the repayment is made or the loan is accelerated prior to first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively, or no prepayment fee if the GA8 Properties are refinanced through HUD. Additionally, we are required to pay an exit fee of $100,000 if the loan is paid off by December 31, 2024, or $140,000 if the loan is paid off after that date. On December 30, 2021, we entered into a mezzanine loan agreement with Oxford for $12.75 million in principal amount. The loan bears interest at LIBOR plus 11.0% with a LIBOR floor of 100 basis points (or with a LIBOR replacement rate), and matures on December 30, 2026. The loan is interest-only and requires a monthly fee in the amount of (i) twenty-two percent (22%) of net cash flow attributable to each month or portion thereof during the loan term, and (ii) five percent (5%) of net cash flow attributable to each month or portion thereof during the post-repayment period which is the earlier of (i) the second anniversary of the loan repayment date and (ii) the date upon which Summit no longer owns any direct or indirect interest in any of the properties and all accrued monthly fees, all excess cash fees and all other liabilities then due agent or lenders are indefeasibly paid in full. The entire Oxford mezzanine loan may be prepaid at any time prior to the three-year anniversary and would be subject at that time to a yield maintenance premium fee equal to the interest that would have been paid for the full three years, which will be due and payable upon the earliest of the maturity or acceleration of the loan, or payment of the loan in full. HUD-insured loans We have six properties with HUD-insured loans from Lument Capital (formerly ORIX Real Estate Capital, LLC) and one property with a HUD-insured loan from Capital One Multifamily Finance, LLC. See table above listing loans payable for further information. All of the HUD-insured loans are subject to customary representations, warranties and ongoing covenants and agreements with respect to the operation of the facilities, including the provision for certain maintenance and other reserve accounts for property tax, insurance, and capital expenditures, with respect to the facilities all as described in the HUD agreements. These reserves are included in restricted cash in our condensed consolidated balance sheets.

Equity-Method Investments

Equity-Method Investments	9 Months Ended
	Sep. 30, 2022
Equity-Method Investments
Equity-Method Investments	5. Equity-Method Investments As of September 30, 2022 and December 31, 2021, the balances of our Equity-Method Investments were approximately $7.6 million and $7.9 million, respectively, and are as follows: Summit Union Life Holdings, LLC The SUL JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the SUL JV (the “SUL LLC Agreement”). Under the SUL LLC Agreement, net operating cash flow of the SUL JV is distributed monthly, first to the Operating Partnership and Best Years pari passu pari passu For the nine months ended September 30, 2022, we invested approximately $821,000 related to capital calls for the SUL JV. In July 2022, the SUL JV entered into an agreement with a broker to market the property, Riverglen House of Littleton, for sale. As of September 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the SUL JV was approximately $3.3 million and $2.9 million, respectively. Summit Fantasia Holdings, LLC The Fantasia JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia JV (the “Fantasia LLC Agreement”). Under the Fantasia LLC Agreement, net operating cash flow of the Fantasia JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu pari passu For the nine months ended September 30, 2022, we invested approximately $290,000 related to capital calls for the Fantasia JV. In June 2022, the Fantasia JV recorded an impairment charge of approximately $3.2 million and we recorded our 35% share of the impairment of approximately $1.1 million in loss from equity-method investees in the condensed consolidated statements of operations for the nine months ended September 30, 2022. Additionally, we determined the fair value of our investment in the Fantasia JV to be impaired and recorded a $0.1 million impairment charge in June 2022 and an additional $0.1 million impairment charge in September 2022 which is recorded in the loss from equity-method investees in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022. In August 2022, the Fantasia JV agreed to sell one property, Sun Oak Assisted Living; therefore the property is considered as Held For Sale in the Fantasia JV as of September 30, 2022. As of September 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the Fantasia JV was approximately $1.1 million and $2.0 million, respectively. Summit Fantasia Holdings II, LLC The Fantasia II JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia II JV (the “Fantasia II LLC Agreement”). Under the Fantasia II LLC Agreement, net operating cash flow of the Fantasia JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu pari passu In October 2022, the Fantasia II JV entered into a purchase and sale agreement to sell their two properties. As of September 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the Fantasia II JV was approximately $1.2 million and $1.3 million, respectively. Summit Fantasia Holdings III, LLC The Fantasia III JV will continue until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia III JV (the “Fantasia III LLC Agreement”). Under the Fantasia III LLC Agreement, net operating cash flow of the Fantasia III JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu pari passu As of September 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the Fantasia III JV was approximately $1.6 million and $1.5 million, respectively. Summit Fantasy Pearl Holdings, LLC The FPH JV will continue until an event of dissolution occurs, as defined in the limited liability company agreement of the FPH JV (the “FPH LLC Agreement”). Under the FPH LLC Agreement, net operating cash flow of the FPH JV is distributed quarterly, first to the members pari passu pari passu As of September 30, 2022 and December 31, 2021, the balance of our equity-method investment related to the FPH JV was approximately $0.4 million and $0.2 million, respectively. Indiana JV In June 2021, we sold our 15% interest in the Indiana JV for approximately $5.4 million in cash. As of September 30, 2022 and December 31, 2021, we have a 0% interest in the Indiana JV. Summarized Financial Data for Equity-Method Investments Our Equity-Method Investments are significant equity-method investments in the aggregate. The results of operations of our Equity-Method Investments for the nine months ended September 30, 2022 are summarized below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fantasia ​ Fantasia ​ Fantasia ​ FPH ​ Combined ​ SUL JV JV II JV III JV JV Total Revenue ​ $ 15,670,000 ​ $ 1,962,000 ​ $ 2,147,000 ​ $ 6,250,000 ​ $ 2,773,000 ​ $ 28,802,000 ​ Income (loss) from operations ​ $ 4,484,000 ​ $ (2,480,000) ​ $ 1,484,000 ​ $ 3,026,000 ​ $ 1,252,000 ​ $ 7,766,000 ​ Net income (loss) ​ $ 910,000 ​ $ (2,692,000) ​ $ 791,000 ​ $ 1,373,000 ​ $ 2,633,000 ​ $ 3,015,000 ​ Summit interest in Equity-Method Investments net income (loss) ​ $ 91,000 ​ $ (942,000) ​ $ 158,000 ​ $ 137,000 ​ $ 263,000 ​ $ (293,000) (1) (1) Included in the loss from equity-method investees in the condensed consolidated statements of operations is an additional $203,000 of impairment related to the Fantasia JV Equity-Method Investment. ​ The results of operations of our Equity-Method Investments for the nine months ended September 30, 2021 are summarized below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fantasia Fantasia Fantasia FPH Indiana Combined ​ ​ SUL JV JV II JV III JV JV ​ JV Total Revenue ​ $ 15,339,000 ​ $ 2,860,000 ​ $ 2,759,000 ​ $ 6,156,000 ​ $ 2,731,000 ​ $ (3,166,000) (1) $ 26,679,000 Income (loss) from operations ​ $ 5,072,000 ​ $ 282,000 ​ $ 1,448,000 ​ $ 3,094,000 ​ $ 1,255,000 ​ $ (5,093,000) ​ $ 6,058,000 Net income (loss) ​ $ 1,421,000 ​ $ 369,000 ​ $ 738,000 ​ $ 1,510,000 ​ $ 1,205,000 ​ $ (8,567,000) ​ $ (3,324,000) Summit interest in Equity-Method Investments net income (loss) ​ $ 142,000 ​ $ 129,000 ​ $ 148,000 ​ $ 151,000 ​ $ 121,000 ​ $ (1,286,000) ​ $ (595,000) (1) This amount has been revised to reflect the revenues of the Indiana JV prior to the sale of our 15% interest, which includes $1.5 million in above-market lease amortization and $0.4 million in interest income. There was no impact on the loss allocated to the Company as a result of this revision. Distributions from Equity-Method Investments As of September 30, 2022 and December 31, 2021, we have distributions receivable, which are included in tenant and other receivables in our condensed consolidated balance sheets, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 SUL JV ​ $ 260,000 ​ $ 273,000 Fantasia JV ​ 235,000 ​ 205,000 Fantasia II JV ​ 49,000 ​ 54,000 Fantasia III JV ​ 27,000 ​ 22,000 FPH JV ​ 64,000 ​ 28,000 Total ​ $ 635,000 ​ $ 582,000 ​ For the nine months ended September 30, 2022 and 2021, we have received cash distributions, which are included in our cash flows from operating activities in tenant and other receivables, and cash flows from investing activities, as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine months Ended September 30, 2022 ​ Nine months Ended September 30, 2021 ​ ​ ​ ​ ​ Cash Flow ​ Cash Flow ​ ​ ​ ​ Cash Flow ​ Cash Flow ​ ​ Total Cash ​ from ​ from ​ Total Cash ​ from ​ from ​ ​ Distributions ​ Operating ​ Investing ​ Distributions ​ Operating ​ Investing ​ Received Activities Activities Received Activities Activities SUL JV ​ $ 434,000 ​ $ 91,000 ​ $ 343,000 ​ $ 631,000 ​ $ 142,000 ​ $ 489,000 Fantasia JV ​ — ​ — ​ — ​ — ​ — ​ — Fantasia II JV ​ 237,000 ​ 158,000 ​ 79,000 ​ 225,000 ​ 148,000 ​ 77,000 Fantasia III JV ​ 95,000 ​ 95,000 ​ — ​ 123,000 ​ 123,000 ​ — FPH JV ​ 56,000 ​ 56,000 ​ — ​ 114,000 ​ 114,000 ​ — Indiana JV ​ ​ — ​ ​ — ​ ​ — ​ ​ 773,000 ​ ​ — ​ ​ 773,000 Total ​ $ 822,000 ​ $ 400,000 ​ $ 422,000 ​ $ 1,866,000 ​ $ 527,000 ​ $ 1,339,000 ​ Asset Management Fees We serve as the manager of our Equity-Method Investments and provide management services in exchange for fees and reimbursements. As the manager, we are paid an annual asset management fee for managing the properties held by our Equity-Method Investments, as defined in those agreements. For each of the three months ended September 30, 2022 and 2021, we recorded approximately $0.2 million in asset management fees from our Equity-Method Investments. For the nine months ended September 30, 2022 and 2021, we recorded approximately $0.5 million and $0.8 million, respectively, in asset management fees from our Equity-Method Investments (see Note 7).

Receivables

Receivables	9 Months Ended
	Sep. 30, 2022
Receivables
Receivables	6. Receivables Tenant and Other Receivables, Net Tenant and other receivables, net consists of: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Straight-line rent receivables ​ $ 3,503,000 ​ $ 2,395,000 Distribution receivables from Equity-Method Investments ​ 635,000 ​ 582,000 Asset management fees ​ 303,000 ​ 323,000 Other receivables ​ 232,000 ​ 86,000 Total ​ $ 4,673,000 ​ $ 3,386,000 ​

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions
Related Party Transactions	7. Related Party Transactions Equity-Method Investments See Notes 5 and 6 for further discussion of distributions and asset management fees related to our Equity-Method Investments.

Intangible Lease Assets

Intangible Lease Assets	9 Months Ended
	Sep. 30, 2022
Intangible Lease Assets
Intangible Lease Assets	8. Intangible Lease Assets Intangible lease assets as of September 30, 2022 and December 31, 2021 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2022 ​ 2021 In-place leases ​ $ 13,778,000 ​ $ 13,778,000 Less: accumulated amortization ​ (707,000) ​ (18,000) In-place leases, net ​ 13,071,000 ​ 13,760,000 Above-market leases ​ 959,000 ​ 959,000 Less: accumulated amortization ​ (80,000) ​ (32,000) Above-market leases, net ​ 879,000 ​ 927,000 Total intangible lease assets, net ​ $ 13,950,000 ​ $ 14,687,000 ​ For the three months ended September 30, 2022 and 2021, amortization expense for intangible lease assets was approximately $0.2 million and $25,000, respectively, of which approximately $16,000 and $16,000, respectively, relates to the amortization of above-market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations. For the nine months ended September 30, 2022 and 2021, amortization expense for intangible lease assets was approximately $0.7 million and $25,000, respectively, of which approximately $48,000 and $16,000, respectively, relates to the amortization of above-market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations. Expected future amortization of the intangible lease assets as of September 30, 2022, for the period from October 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows: ​ ​ ​ ​ ​ Years ending December 31, ​ October 1, 2022 to December 31, 2022 ​ $ 244,000 2023 ​ 980,000 2024 ​ 980,000 2025 ​ 980,000 2026 ​ 980,000 Thereafter ​ 9,786,000 ​ ​ $ 13,950,000 ​

Right of Use (ROU) Asset - Oper

Right of Use (ROU) Asset - Operating	9 Months Ended
	Sep. 30, 2022
Right of Use (ROU) Asset - Operating
Right of Use (ROU) Asset - Operating	9. Right of Use (ROU) Asset - Operating On April 1, 2022, we entered into a temporary space license agreement (“Temporary License”) and a standard office lease (“New Lease”) with Lakehills CM-CG LLC (collectively, the “LH Lease”). The Temporary License, for space located in Laguna Hills, California, began on April 22, 2022 and expires on the date we move out of such temporary office space or five Concurrent with the execution of the Temporary License, we entered into the New Lease which will begin in November 2022 for a period of sixty-six The LH Lease is classified as an operating lease. An ROU asset represents the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The LH Lease did not provide an explicit rate of interest; therefore we used an estimated incremental borrowing rate of 5% based on a fully collateralized and fully amortizing loan with a maturity date of the same length as the lease that is based on information available at the commencement date in determining the present value of lease payments. At inception, we recorded an ROU asset and lease liability Supplemental balance sheet information related to the LH Lease as of September 30, 2022 is as follows: ​ ​ ​ ​ ​ ​ Component Consolidated Balance Sheet Caption Right of use asset - operating Other assets, net ​ $ 856,000 Lease liability - operating Accounts payable and accrued liabilities ​ $ 907,000 ​ Lease expense is presented as part of continuing operations within general and administrative expenses in the condensed consolidated statements of operations. For the three months ended September 30, 2022, we recognized approximately $30,000 in lease expense and we were not required to make any rent payments. For the nine months ended September 30, 2022, we recognized approximately $50,000 in lease expense and we were not required to make any rent payments. The lease payments will be classified within operating activities in the consolidated statements of cash flows. As of September 30, 2022, we had not made any lease payments and the weighted average remaining lease term is 5.6 years. Pursuant to ASC 842, lease payments on the LH Lease for the period from October 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows: ​ ​ ​ ​ Year Lease payments October 1, 2022 to December 31, 2022 ​ $ 17,000 2023 ​ 120,000 2024 ​ 212,000 2025 ​ 218,000 2026 ​ 224,000 Thereafter ​ 310,000 Total lease payments ​ $ 1,101,000 Less imputed interest ($155,000) and moving expense reimbursement ($39,000) ​ (194,000) Total lease liability ​ $ 907,000 ​

Concentration of Risk

Concentration of Risk	9 Months Ended
	Sep. 30, 2022
Concentration of Risk
Concentration of Risk	10. Concentration of Risk Our cash is generally invested in short-term money market instruments. As of September 30, 2022, we had cash and cash equivalent accounts in excess of FDIC-insured limits. However, we do not believe the risk associated with this excess is significant. As of September 30, 2022, we owned eight properties in Georgia, four properties in California, three properties in Oregon, one property in Texas, one property in Illinois, and one property in Arizona (excluding the 35 properties held by our Equity-Method Investments). Accordingly, there is a geographic concentration of risk subject to economic conditions in certain states. Additionally, for the three months ended September 30, 2022, 16 of our real estate properties were leased to 14 different tenants under long-term triple net leases, and three of the 14 tenants each represented more than 10% of our rental revenue. For the three months ended September 30, 2021, we leased our 10 real estate properties to eight different tenants under long-term triple net leases, and four of the eight tenants each represented more than 10% of our rental revenue. For the nine months ended September 30, 2022, 16 of our real estate properties were leased to 14 different tenants under long-term triple net leases, and three of the 14 tenants each represented more than 10% of our rental revenue. For the nine months ended September 30, 2021, we leased our 10 real estate properties to eight different tenants under long-term triple net leases, and three of the eight tenants each represented more than 10% of our rental revenue. As of September 30, 2022, our GA8 Properties are considered to be a significant asset concentration as the aggregate net assets of the GA8 Properties were greater than 20% of our total assets due to cross-default provisions in the leases.

Fair Value Measurements of Fina

Fair Value Measurements of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value Measurements of Financial Instruments
Fair Value Measurements of Financial Instruments	11. Fair Value Measurements of Financial Instruments Our condensed consolidated balance sheets include the following financial instruments: cash and cash equivalents, restricted cash, tenant and other receivables, certain other assets, accounts payable and accrued liabilities, security deposits and loans payable. With the exception of the HUD-insured loans payable discussed below, we consider the carrying values to approximate fair value for such financial instruments because of the short period of time between origination of the instruments and their expected payment and for our Oxford and CIBC loans (per Note 4), the carrying amount approximates fair value because the borrowings are based on variable market interest rates. As of September 30, 2022 and December 31, 2021, the fair value of our HUD-insured loans payable was $35.6 million and $52.5 million, compared to the principal balance (excluding debt discount) of $45.3 million and $46.1 million, respectively. The fair value of loans payable was estimated using lending rates available to us for financial instruments with similar terms and maturities. To estimate fair value as of September 30, 2022, we used cash flow analyses, based on current interest rates for similar types of borrowing arrangements. As the inputs to our valuation estimate are neither observable in nor supported by market activity, our loans payable are classified as Level 3 liability within the fair value hierarchy. As a result of our ongoing analysis for potential impairment of our investments in real estate, we may be required to adjust the carrying value of certain assets to their estimated fair values, or estimated fair value less selling costs, under certain circumstances. No impairments were recorded during the three and nine months ended September 30, 2022 and 2021. At September 30, 2022 and December 31, 2021, we do not have any financial assets or financial liabilities that are measured at fair value on a recurring basis in our condensed consolidated financial statements.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies
Commitments and Contingencies	12. Commitments and Contingencies We inspect our properties under a Phase I assessment for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liability with respect to the properties that would have a material effect on our consolidated financial condition, results of operations and cash flows. Further, we are not aware of any environmental liability or any unasserted claim or assessment with respect to an environmental liability that we believe would require additional disclosure or the recording of a loss contingency. Our commitments and contingencies include the usual obligations of real estate owners and licensed operators in the normal course of business. In the opinion of management, these matters are not expected to have a material impact on our consolidated financial condition, results of operations and cash flows. We are also subject to contingent losses resulting from litigation against the Company. Legal Proceedings In September 2015, a bankruptcy petition was filed against Healthcare Real Estate Partners, LLC (“HCRE”) by the investors in Healthcare Real Estate Fund, LLC and Healthcare Real Estate Qualified Purchasers Fund, LLC (collectively, the “Funds”). HCRE did not timely respond to the involuntary petition and the Bankruptcy Court entered an Order of Relief making HCRE a debtor in bankruptcy. As a result, HCRE was removed as manager under the Funds’ operating agreement. Thereafter the Company became the manager of the Funds and purchased the investors’ interests in the Funds for approximately $0.9 million. Following the subsequent dismissal of the involuntary bankruptcy petition filed against it, HCRE filed a motion for attorneys’ fees and damages and a separate complaint for violation of the automatic stay against the petitioning creditors and the Company in the United States Bankruptcy Court of the District of Delaware. The Bankruptcy Court granted a motion to dismiss the complaint for violation of the automatic stay filed jointly by the petitioning creditors and us, and dismissed the complaint with prejudice. HCRE appealed the Bankruptcy Court’s decision to the United States District Court for the District of Delaware which affirmed the Bankruptcy Court’s dismissal of the complaint in a decision dated September 9, 2018. On October 11, 2018, HCRE appealed the District Court’s decision affirming the Bankruptcy Court’s dismissal of the complaint to the United States Court of Appeals for the Third Circuit. On October 22, 2019, the Third Circuit granted HCRE’s appeal, reversing the District Court and holding that HCRE could assert the adversary complaint seeking damages for violation of the automatic stay. The Company filed a Petition for Rehearing on November 5, 2019 asserting that HCRE is not entitled to assert a claim for damages for violation of the automatic stay. This Petition was denied and the mandate was issued sending the matter back to the Bankruptcy Court. The Bankruptcy Court held a status conference on February 4, 2021, and subsequently entered scheduling orders to govern discovery and pretrial matters, and discovery is ongoing. The parties have filed dispositive motions, including a motion filed by the Company and the petitioning creditors for judgment on the pleadings. On February 4, 2022, the Bankruptcy Court entered an order denying the motion for judgment on the pleadings on the basis that the Bankruptcy Court would consider the points raised therein after trial. The Bankruptcy Court also entered an order denying HCRE’s motion to dismiss certain counterclaims and severing certain other counterclaims asserted by the petitioning creditors and the Company against HCRE on jurisdictional grounds, with the effect that such counterclaims may be pursued in the United States District Court. The Bankruptcy Court has completed discovery and scheduled a trial date for January 9, 2023. Based on the assessment by management, the Company believes that a loss is currently not probable or estimable under ASC 450, “Contingencies”, and as of September 30, 2022 and December 31, 2021 no accrual has been made with regard to the claim. Indemnification and Employment Agreements We have entered into indemnification agreements with certain of our executive officers and directors which indemnify them against all judgments, penalties, fines and amounts paid in settlement and all expenses actually and reasonably incurred by him or her in connection with any proceeding. Additionally, effective October 19, 2021, we entered into new employment agreements with our executive officers for a term of three years. These employment agreements include customary terms relating to salary, bonus, position, duties and benefits (including eligibility for equity compensation), as well as a cash payment following a change in control of the Company, as defined in such agreements. Management of our Equity-Method Investments As the manager of our Equity-Method Investments, we are responsible for the day-to-day management. Additionally, we could be subject to a capital call from our Equity-Method Investments (see Note 5).

Equity

Equity	9 Months Ended
	Sep. 30, 2022
Equity
Equity	13. Equity Share-Based Compensation Plans Upon the grant of stock options, we determine the exercise price by using our estimated per-share value, which is calculated by aggregating the estimated fair value of our investments in real estate and the estimated fair value of our other assets, subtracting the book value of our liabilities, utilizing a discount for the fact that the shares are not currently traded on a national securities exchange and a lack of a control premium, and divided by the total by the number of our common shares outstanding at the time the options were granted. The fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model. Assumptions required by the model include the risk-free interest rate, the expected life of the options, the expected stock price volatility over the expected life of the options, and the expected distribution yield. Compensation expense for employee stock options is recognized ratably over the vesting term. The expected life of the options was based on the simplified method as we do not have sufficient historical exercise data. The risk-free interest rate was based on the U.S. Treasury yield curve at the date of grant with maturity dates approximating the expected term of the options at the date of grant. Volatility was based on historical volatility of the stock prices for a sample of publicly traded companies with risk profiles similar to ours. The valuation model applied in this calculation utilizes highly subjective assumptions that could potentially change over time, including the expected stock price volatility and the expected life of an option. On April 1, 2022, we granted 81,000 stock options to our non-executive employees under our Summit Healthcare REIT, Inc. 2015 Omnibus Incentive Plan (“Incentive Plan”). The stock options vest monthly beginning on May 1, 2022 and continuing over a three-year period through April 1, 2025. The options expire 10 years from the grant date. The weighted-average fair value per share of the stock options granted was $0.91. The estimated fair value using the Black-Scholes option-pricing model with the following weighted average assumptions: ​ ​ ​ ​ ​ ​ ​ 2022 Stock options granted ​ 81,000 ​ Expected volatility ​ 36.5 % Expected term ​ 5.75 years Risk-free interest rate ​ 2.53 % Dividend yield ​ 0 % Fair value per share ​ $ 0.91 ​ ​ The following table summarizes our stock options as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ Aggregate ​ ​ ​ ​ Exercise ​ Contractual ​ Intrinsic ​ Options Price Term Value Options outstanding at January 1, 2022 1,867,908 ​ $ 2.09 ​ ​ ​ Granted 81,000 ​ 2.35 ​ ​ ​ Exercised — ​ ​ ​ ​ ​ Cancelled/forfeited — ​ ​ ​ ​ ​ Options outstanding at September 30, 2022 1,948,908 ​ $ 2.10 5.24 ​ $ 1,644,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Options exercisable at September 30, 2022 1,874,380 ​ $ 2.09 5.08 ​ $ 1,600,000 ​ For our outstanding non-vested options as of September 30, 2022, the weighted average grant date fair value per share was $0.89. As of September 30, 2022, we have unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized as follows: ​ ​ ​ ​ ​ Years Ending December 31, ​ ​ October 1, 2022 to December 31, 2022 ​ $ 8,000 2023 ​ 25,000 2024 ​ 25,000 2025 ​ 8,000 ​ ​ $ 66,000 ​ The stock-based compensation expense reported for the three months ended September 30, 2022 and 2021 was approximately $9,000 and $9,000, respectively, and is included in general and administrative expense in the condensed consolidated statements of operations. The stock-based compensation expense reported for the nine months ended September 30, 2022 and 2021 was approximately $23,000 and $56,000, respectively, and is included in general and administrative expense in the condensed consolidated statements of operations.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share
Earnings Per Share	14. Earnings Per Share The following table presents the calculation of basic and diluted earnings per share (“EPS”) for the Company’s common stock for the three and nine months ended September 30, 2022 and 2021, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ (Loss) income ​ $ (1,976,000) ​ $ (229,000) ​ $ (4,458,000) ​ $ 604,000 (Income) loss attributable to noncontrolling interest ​ ​ (12,000) ​ ​ (18,000) ​ (49,000) ​ (58,000) Net (loss) income applicable to common stockholders ​ $ (1,988,000) ​ $ (247,000) ​ $ (4,507,000) ​ $ 546,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator for basic EPS - weighted average shares ​ ​ 23,027,978 ​ ​ 23,027,978 ​ 23,027,978 ​ 23,027,978 Effect of dilutive shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Stock options ​ ​ — ​ ​ — ​ — ​ 525,628 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator for diluted EPS – adjusted weighted average shares ​ ​ 23,027,978 ​ ​ 23,027,978 ​ 23,027,978 ​ 23,553,606 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic EPS ​ $ (0.09) ​ $ (0.01) ​ $ (0.20) ​ $ 0.02 Diluted EPS ​ $ (0.09) ​ $ (0.01) ​ $ (0.20) ​ $ 0.02 ​ Stock options to purchase 559,275 shares of common stock were excluded from the calculation for the three and nine months ending September 30, 2022, and 525,628 shares of common stock were excluded from the calculation for the three months ending September 30, 2021, because the effect would be antidilutive.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Summary of Significant Accounting Policies
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The accompanying condensed consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries, the Operating Partnership and its consolidated companies and are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). All intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial information reflects all adjustments, which are, in the opinion of management, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.
Restricted Cash	Restricted Cash The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown on the condensed consolidated statements of cash flows. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Cash and cash equivalents ​ $ 12,089,000 ​ $ 10,488,000 Restricted cash ​ 2,825,000 ​ 2,673,000 Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows ​ $ 14,914,000 ​ $ 13,161,000
Coronavirus (COVID-19)	Coronavirus (COVID-19) The world was, and continues to be, impacted by the COVID-19 pandemic. The healthcare industry was among those most adversely affected by the COVID-19 pandemic. Two of our tenants have experienced a material adverse effect on their operations related to COVID-19, which has affected their ability to make rent payments in 2022 and 2021 (see Note 3 for further information on its impact on us). The extent to which COVID-19 could continue to impact our business, cash flow and results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence. The fluidity of this situation precludes any prediction as to the ultimate material adverse impact on the demand for senior housing and skilled nursing and presents material uncertainty and risk with respect to our business, operations, financial condition and liquidity, including recording impairments, lease modifications and credit losses in future periods.
Reclassification of Intangible Lease Assets	Reclassification of Intangible Lease Assets The following table provides a reconciliation for the reclassification of our intangible lease assets as of December 31, 2021 in our consolidated ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As previously reported Increase (decrease) As reclassified Real estate properties, net ​ $ 192,862,000 ​ $ (13,760,000) ​ $ 179,102,000 Intangible lease assets, net ​ $ — ​ $ 14,687,000 ​ $ 14,687,000 Other assets, net ​ $ 1,349,000 ​ $ (927,000) ​ $ 422,000 Total assets ​ $ 219,126,000 ​ $ — ​ $ 219,126,000 ​ The intangible lease assets related to our prior acquisitions in 2021 were reclassified from real estate properties, net and other assets, net into a separate line item as of September 30, 2022. The result of this reclassification did not have any effect on our total assets, liabilities, accumulated deficit, net loss or statements of cash flows.
Revenue Recognition - Resident Fees and Services	Revenue Recognition - Resident Fees and Services We recognize resident fees and services revenue at the amount that we expect to be entitled to in exchange for providing resident care and services. Resident fees are recognized and billed monthly based on the contracted rate in the resident lease agreements and the reimbursements from Medicaid are based on contracted reimbursement rates. These amounts are paid directly from the residents and/or third-party payors (currently only Medicaid). Revenue is recognized as performance obligations are satisfied. Performance obligations are determined based on the nature of the services provided by us. The majority of resident fees and services is attributable to the portion of the base monthly lease fee in the resident lease agreement. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes the resident fee revenue based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the lease component is the predominant component and the services included under the resident agreements have the same timing and pattern of transfer and are performance obligations that are satisfied over time. Resident services consist of care level services and certain other ancillary services (i.e., housekeeping, laundry, etc.). These services are provided and paid for in addition to the standard fees included in each resident lease (i.e., room and board, standard meals, etc.). Settlements with third-party payors for retroactive adjustments due to audits, reviews or investigations are considered variable consideration and are included in the determination of the estimated transaction price for providing patient care. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and our historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known (that is, new information becomes available), or as years are settled or are no longer subject to such audits, reviews and investigation.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Summary of Significant Accounting Policies
Schedule of reconciliation of cash, cash equivalents, and restricted cash	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Cash and cash equivalents ​ $ 12,089,000 ​ $ 10,488,000 Restricted cash ​ 2,825,000 ​ 2,673,000 Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows ​ $ 14,914,000 ​ $ 13,161,000
Schedule of reconciliation for reclassification of intangible lease assets	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As previously reported Increase (decrease) As reclassified Real estate properties, net ​ $ 192,862,000 ​ $ (13,760,000) ​ $ 179,102,000 Intangible lease assets, net ​ $ — ​ $ 14,687,000 ​ $ 14,687,000 Other assets, net ​ $ 1,349,000 ​ $ (927,000) ​ $ 422,000 Total assets ​ $ 219,126,000 ​ $ — ​ $ 219,126,000

Investments in Real Estate Pr_2

Investments in Real Estate Properties (Tables)	9 Months Ended
	Sep. 30, 2022
Investments in Real Estate Properties
Schedule of investments in real estate properties	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Land ​ $ 15,565,000 ​ $ 15,565,000 Buildings and improvements ​ 166,989,000 ​ 166,989,000 Less: accumulated depreciation ​ (14,840,000) ​ (11,395,000) Buildings and improvements, net ​ 152,149,000 ​ 155,594,000 Furniture and fixtures ​ 12,440,000 ​ 12,137,000 Less: accumulated depreciation ​ (5,471,000) ​ (4,194,000) Furniture and fixtures, net ​ 6,969,000 ​ 7,943,000 Real estate properties, net ​ $ 174,683,000 ​ $ 179,102,000
Schedule of real estate properties	The following table provides summary information regarding our portfolio (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the $12.75 million loan from Oxford Finance, LLC (“Oxford”) (see Note 4) with Summit Georgia Holdings LLC, our wholly-owned subsidiary) as of September 30, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Payable, ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Excluding ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Debt ​ ​ ​ ​ ​ ​ ​ ​ Purchase ​ Issuance Property Location Date Purchased Type (1) Price Costs Sheridan Care Center Sheridan, OR ​ August 3, 2012 SNF ​ $ 4,100,000 ​ $ 4,044,000 Fernhill Care Center Portland, OR ​ August 3, 2012 SNF ​ 4,500,000 ​ 3,548,000 Friendship Haven Healthcare and Rehabilitation Center Galveston County, TX ​ September 14, 2012 SNF ​ 15,000,000 ​ 11,381,000 Pacific Health and Rehabilitation Center Tigard, OR ​ December 24, 2012 SNF ​ 8,140,000 ​ 5,915,000 Brookstone of Aledo Aledo, IL ​ July 2, 2013 AL ​ 8,625,000 ​ 6,633,000 Sundial Assisted Living (2) Redding, CA ​ December 18, 2013 AL ​ 3,500,000 ​ 3,698,000 Pennington Gardens (2) Chandler, AZ ​ July 17, 2017 AL/MC ​ 13,400,000 ​ 10,078,000 Yucaipa Hill Post Acute ​ Yucaipa, CA ​ July 2, 2021 ​ SNF ​ ​ 10,715,000 ​ ​ 8,014,000 Creekside Post Acute ​ Yucaipa, CA ​ July 2, 2021 ​ SNF ​ ​ 4,780,000 ​ ​ 3,575,000 University Post Acute ​ Mentone, CA ​ July 2, 2021 ​ SNF ​ ​ 4,560,000 ​ ​ 3,411,000 Calhoun Health Center ​ Calhoun, GA ​ December 30, 2021 ​ SNF ​ ​ 7,670,000 ​ ​ 6,549,000 Maple Ridge Health Care Center ​ Cartersville, GA ​ December 30, 2021 ​ SNF ​ ​ 13,548,000 ​ ​ 11,568,000 Chatsworth Health Care Center ​ Chatsworth, GA ​ December 30, 2021 ​ SNF ​ ​ 29,785,000 ​ ​ 25,432,000 East Lake Arbor ​ Decatur, GA ​ December 30, 2021 ​ SNF ​ ​ 15,640,000 ​ ​ 13,354,000 Fairburn Health Care Center ​ Fairburn, GA ​ December 30, 2021 ​ SNF ​ ​ 14,644,000 ​ ​ 12,503,000 Grandview Health Care Center ​ Jasper, GA ​ December 30, 2021 ​ SNF ​ ​ 10,061,000 ​ ​ 8,591,000 Rosemont at Stone Mountain ​ Stone Mountain, GA ​ December 30, 2021 ​ SNF ​ ​ 23,908,000 ​ ​ 20,414,000 Willowwood Nursing Center & Rehab ​ Flowery Branch, GA ​ December 30, 2021 ​ SNF ​ ​ 14,744,000 ​ ​ 12,589,000 Total: ​ ​ ​ ​ ​ ​ $ 207,320,000 ​ $ 171,297,000 (1) SNF is an abbreviation for skilled nursing facility. AL is an abbreviation for assisted living facility. MC is an abbreviation for memory care facility. (2) See above under Pennington Gardens Operations LLC and Sundial Operations LLC.
Schedule of future minimum lease payments	​ ​ ​ ​ ​ Years ending ​ ​ October 1, 2022 to December 31, 2022 ​ $ 4,433,000 2023 ​ 17,983,000 2024 ​ 18,272,000 2025 ​ 18,566,000 2026 ​ 18,865,000 Thereafter ​ 165,462,000 ​ ​ $ 243,581,000

Loans Payable (Tables)

Loans Payable (Tables)	9 Months Ended
	Sep. 30, 2022
Loans Payable
Schedule of debt	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2022 December 31, 2021 Loans payable to Lument (formerly ORIX Real Estate Capital, LLC) (insured by HUD) in monthly installments of approximately $183,000, including interest, ranging from a fixed rate of 2.79% to 4.2%, due in September 2039 through April 2055, and as of September 30, 2022 and December 31, 2021, collateralized by Sheridan, Fernhill, Pacific Health, Aledo, Sundial and Friendship Haven. ​ $ 35,219,000 ​ $ 35,934,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to Capital One Multifamily Finance, LLC (insured by HUD) in monthly installments of approximately $49,000, including interest at a fixed rate of 4.23%, due in September 2053, and collateralized by Pennington Gardens. ​ ​ 10,078,000 ​ ​ 10,194,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to CIBC Bank, USA in monthly installments of approximately of $106,000 including cash collateral fund payments, variable interest rate as noted below (6.63% and 5% at September 30, 2022 and December 31, 2021, respectively), due in July 2024, and as of December 31, 2021, collateralized by Yucaipa Hill Post Acute, Creekside Post Acute and University Post Acute. ​ ​ 15,000,000 ​ ​ 15,000,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to CIBC Bank, USA in monthly installments of approximately $459,000 (interest only through December 2023) variable interest rate as noted below (6.1% and 4% at September 30, 2022 and December 31, 2021, respectively), due in December 2024, and as of September 30, 2022 and December 31, 2021, collateralized by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab. ​ ​ 91,000,000 ​ ​ 91,000,000 ​ ​ ​ ​ ​ ​ ​ Loan payable to Oxford Finance, LLC in monthly installments of approximately $226,000 (interest only through maturity), variable interest rate as noted below (13.6% and 12% at September 30, 2022 and December 31, 2021, respectively) due in March 2025, collateralized in second position by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab. ​ ​ 20,000,000 ​ ​ 20,000,000 ​ ​ ​ ​ ​ ​ ​ Mezzanine Loan payable to Oxford Finance, LLC in monthly installments of approximately $144,000 (interest only through maturity), variable interest rate as noted below (13.6% and 12% at September 30, 2022 and December 31, 2021, respectively) due in December 2026, secured by the equity interests of our wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties. ​ ​ 12,750,000 ​ ​ 12,750,000 ​ ​ 184,047,000 ​ 184,878,000 Less debt issuance costs ​ (3,824,000) ​ (4,508,000) Total loans payable ​ $ 180,223,000 ​ $ 180,370,000
Schedule of maturities of long-term debt	The principal payments due on the loans payable (excluding debt issuance costs and cash collateral funds) for the period from October 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows: ​ ​ ​ ​ ​ ​ ​ Principal Years Ending Amount October 1, 2022 to December 31, 2022 ​ $ 283,000 2023 ​ 1,158,000 2024 ​ 107,201,000 2025 ​ 21,246,000 2026 ​ 14,042,000 Thereafter ​ 40,117,000 ​ ​ $ 184,047,000

Equity-Method Investments (Tabl

Equity-Method Investments (Tables)	9 Months Ended
	Sep. 30, 2022
Equity-Method Investments
Schedule of results of operations	The results of operations of our Equity-Method Investments for the nine months ended September 30, 2022 are summarized below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fantasia ​ Fantasia ​ Fantasia ​ FPH ​ Combined ​ SUL JV JV II JV III JV JV Total Revenue ​ $ 15,670,000 ​ $ 1,962,000 ​ $ 2,147,000 ​ $ 6,250,000 ​ $ 2,773,000 ​ $ 28,802,000 ​ Income (loss) from operations ​ $ 4,484,000 ​ $ (2,480,000) ​ $ 1,484,000 ​ $ 3,026,000 ​ $ 1,252,000 ​ $ 7,766,000 ​ Net income (loss) ​ $ 910,000 ​ $ (2,692,000) ​ $ 791,000 ​ $ 1,373,000 ​ $ 2,633,000 ​ $ 3,015,000 ​ Summit interest in Equity-Method Investments net income (loss) ​ $ 91,000 ​ $ (942,000) ​ $ 158,000 ​ $ 137,000 ​ $ 263,000 ​ $ (293,000) (1) (1) Included in the loss from equity-method investees in the condensed consolidated statements of operations is an additional $203,000 of impairment related to the Fantasia JV Equity-Method Investment. ​ The results of operations of our Equity-Method Investments for the nine months ended September 30, 2021 are summarized below: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fantasia Fantasia Fantasia FPH Indiana Combined ​ ​ SUL JV JV II JV III JV JV ​ JV Total Revenue ​ $ 15,339,000 ​ $ 2,860,000 ​ $ 2,759,000 ​ $ 6,156,000 ​ $ 2,731,000 ​ $ (3,166,000) (1) $ 26,679,000 Income (loss) from operations ​ $ 5,072,000 ​ $ 282,000 ​ $ 1,448,000 ​ $ 3,094,000 ​ $ 1,255,000 ​ $ (5,093,000) ​ $ 6,058,000 Net income (loss) ​ $ 1,421,000 ​ $ 369,000 ​ $ 738,000 ​ $ 1,510,000 ​ $ 1,205,000 ​ $ (8,567,000) ​ $ (3,324,000) Summit interest in Equity-Method Investments net income (loss) ​ $ 142,000 ​ $ 129,000 ​ $ 148,000 ​ $ 151,000 ​ $ 121,000 ​ $ (1,286,000) ​ $ (595,000) (1) This amount has been revised to reflect the revenues of the Indiana JV prior to the sale of our 15% interest, which includes $1.5 million in above-market lease amortization and $0.4 million in interest income. There was no impact on the loss allocated to the Company as a result of this revision.
Schedule of distributions receivable	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 SUL JV ​ $ 260,000 ​ $ 273,000 Fantasia JV ​ 235,000 ​ 205,000 Fantasia II JV ​ 49,000 ​ 54,000 Fantasia III JV ​ 27,000 ​ 22,000 FPH JV ​ 64,000 ​ 28,000 Total ​ $ 635,000 ​ $ 582,000
Schedule of cash distributions	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Nine months Ended September 30, 2022 ​ Nine months Ended September 30, 2021 ​ ​ ​ ​ ​ Cash Flow ​ Cash Flow ​ ​ ​ ​ Cash Flow ​ Cash Flow ​ ​ Total Cash ​ from ​ from ​ Total Cash ​ from ​ from ​ ​ Distributions ​ Operating ​ Investing ​ Distributions ​ Operating ​ Investing ​ Received Activities Activities Received Activities Activities SUL JV ​ $ 434,000 ​ $ 91,000 ​ $ 343,000 ​ $ 631,000 ​ $ 142,000 ​ $ 489,000 Fantasia JV ​ — ​ — ​ — ​ — ​ — ​ — Fantasia II JV ​ 237,000 ​ 158,000 ​ 79,000 ​ 225,000 ​ 148,000 ​ 77,000 Fantasia III JV ​ 95,000 ​ 95,000 ​ — ​ 123,000 ​ 123,000 ​ — FPH JV ​ 56,000 ​ 56,000 ​ — ​ 114,000 ​ 114,000 ​ — Indiana JV ​ ​ — ​ ​ — ​ ​ — ​ ​ 773,000 ​ ​ — ​ ​ 773,000 Total ​ $ 822,000 ​ $ 400,000 ​ $ 422,000 ​ $ 1,866,000 ​ $ 527,000 ​ $ 1,339,000

Receivables (Tables)

Receivables (Tables)	9 Months Ended
	Sep. 30, 2022
Receivables
Schedule of tenant and other receivables	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ 2022 2021 Straight-line rent receivables ​ $ 3,503,000 ​ $ 2,395,000 Distribution receivables from Equity-Method Investments ​ 635,000 ​ 582,000 Asset management fees ​ 303,000 ​ 323,000 Other receivables ​ 232,000 ​ 86,000 Total ​ $ 4,673,000 ​ $ 3,386,000

Intangible Lease Assets (Tables

Intangible Lease Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Intangible Lease Assets
Schedule of intangible lease assets	​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, ​ ​ 2022 ​ 2021 In-place leases ​ $ 13,778,000 ​ $ 13,778,000 Less: accumulated amortization ​ (707,000) ​ (18,000) In-place leases, net ​ 13,071,000 ​ 13,760,000 Above-market leases ​ 959,000 ​ 959,000 Less: accumulated amortization ​ (80,000) ​ (32,000) Above-market leases, net ​ 879,000 ​ 927,000 Total intangible lease assets, net ​ $ 13,950,000 ​ $ 14,687,000 ​
Schedule of expected future amortization of the intangible lease assets	​ ​ ​ ​ ​ Years ending December 31, ​ October 1, 2022 to December 31, 2022 ​ $ 244,000 2023 ​ 980,000 2024 ​ 980,000 2025 ​ 980,000 2026 ​ 980,000 Thereafter ​ 9,786,000 ​ ​ $ 13,950,000

Right of Use (ROU) Asset - Op_2

Right of Use (ROU) Asset - Operating (Tables)	9 Months Ended
	Sep. 30, 2022
Right of Use (ROU) Asset - Operating
Summary of supplemental balance sheet information related to the LH Lease	Supplemental balance sheet information related to the LH Lease as of September 30, 2022 is as follows: ​ ​ ​ ​ ​ ​ Component Consolidated Balance Sheet Caption Right of use asset - operating Other assets, net ​ $ 856,000 Lease liability - operating Accounts payable and accrued liabilities ​ $ 907,000
Schedule of lease payments on the LH Lease	Pursuant to ASC 842, lease payments on the LH Lease for the period from October 1, 2022 to December 31, 2022 and for each of the four following years and thereafter ending December 31 are as follows: ​ ​ ​ ​ Year Lease payments October 1, 2022 to December 31, 2022 ​ $ 17,000 2023 ​ 120,000 2024 ​ 212,000 2025 ​ 218,000 2026 ​ 224,000 Thereafter ​ 310,000 Total lease payments ​ $ 1,101,000 Less imputed interest ($155,000) and moving expense reimbursement ($39,000) ​ (194,000) Total lease liability ​ $ 907,000

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Equity
Schedule of estimated fair value using assumptions	​ ​ ​ ​ ​ ​ ​ 2022 Stock options granted ​ 81,000 ​ Expected volatility ​ 36.5 % Expected term ​ 5.75 years Risk-free interest rate ​ 2.53 % Dividend yield ​ 0 % Fair value per share ​ $ 0.91 ​
Schedule of stock options	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ Weighted ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ Aggregate ​ ​ ​ ​ Exercise ​ Contractual ​ Intrinsic ​ Options Price Term Value Options outstanding at January 1, 2022 1,867,908 ​ $ 2.09 ​ ​ ​ Granted 81,000 ​ 2.35 ​ ​ ​ Exercised — ​ ​ ​ ​ ​ Cancelled/forfeited — ​ ​ ​ ​ ​ Options outstanding at September 30, 2022 1,948,908 ​ $ 2.10 5.24 ​ $ 1,644,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Options exercisable at September 30, 2022 1,874,380 ​ $ 2.09 5.08 ​ $ 1,600,000
Schedule of unrecognized stock-based compensation expense	​ ​ ​ ​ ​ Years Ending December 31, ​ ​ October 1, 2022 to December 31, 2022 ​ $ 8,000 2023 ​ 25,000 2024 ​ 25,000 2025 ​ 8,000 ​ ​ $ 66,000

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share
Schedule of basic and diluted earning per share and reconciliation weighted average common stock outstanding	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine months Ended ​ ​ September 30, ​ September 30, ​ 2022 2021 2022 2021 Numerator: ​ ​ ​ ​ ​ ​ ​ ​ (Loss) income ​ $ (1,976,000) ​ $ (229,000) ​ $ (4,458,000) ​ $ 604,000 (Income) loss attributable to noncontrolling interest ​ ​ (12,000) ​ ​ (18,000) ​ (49,000) ​ (58,000) Net (loss) income applicable to common stockholders ​ $ (1,988,000) ​ $ (247,000) ​ $ (4,507,000) ​ $ 546,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator for basic EPS - weighted average shares ​ ​ 23,027,978 ​ ​ 23,027,978 ​ 23,027,978 ​ 23,027,978 Effect of dilutive shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Stock options ​ ​ — ​ ​ — ​ — ​ 525,628 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator for diluted EPS – adjusted weighted average shares ​ ​ 23,027,978 ​ ​ 23,027,978 ​ 23,027,978 ​ 23,553,606 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic EPS ​ $ (0.09) ​ $ (0.01) ​ $ (0.20) ​ $ 0.02 Diluted EPS ​ $ (0.09) ​ $ (0.01) ​ $ (0.20) ​ $ 0.02

Organization (Details)

Organization (Details)	1 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2021 USD ($) property	Sep. 30, 2022 USD ($) property	Dec. 31, 2021 USD ($) property
Organization
Equity-method investments | $		$ 7,640,000	$ 7,902,000
Number of owned properties		17
Unconsolidated
Organization
Equity method investment ownership percentage		10%
Summit Healthcare Operating Partnership, L.P
Organization
Limited partnership interest		99.88%
Summit Healthcare Operating Partnership, L.P | Cornerstone Realty Advisors, LLC
Organization
Limited partnership interest		0.12%
Cornerstone Healthcare Partners LLC
Organization
Limited partnership interest		95%
Cornerstone Healthcare Real Estate Fund
Organization
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest by affiliates		5%
JV Properties
Organization
Noncontrolling interest, ownership percentage by noncontrolling owners		4.70%	4.70%
Number of owned properties		4	4
Summit Union Life Holdings, LLC
Organization
Real estate investment trust own percentage		10%
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest by affiliates		10%	10%
Number of owned properties		17	17
Four Jv Properties
Organization
Limited partnership interest		95.30%
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest by affiliates		95.30%	95.30%
Fantasia III JV
Organization
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest by affiliates		10%	10%
Number of owned properties		9	9
Summit Fantasy Pearl Holdings, LLC
Organization
Limited partnership interest		10%	10%
Number of owned properties		6	6
Fantasia II JV
Organization
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest by affiliates		20%
Number of owned properties		2	2
Fantasia II JV | Indiana JV
Organization
Equity method investment ownership percentage		20%	20%
Fantasia JV
Organization
Limited partnership interest		35%
Limited liability company (LLC) or limited partnership (LP), members or limited partners, ownership interest by affiliates		35%	35%
Number of owned properties		1	2
Summit Health Care Three Properties | Fantasia JV
Organization
Equity method investment ownership percentage		100%
Indiana JV
Organization
Limited partnership interest	15%
Equity-method investments | $	$ 5,400,000
Number of owned properties	14
Indiana JV | Indiana JV
Organization
Equity method investment ownership percentage		0%	0%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies
Cash and cash equivalents	$ 12,089,000	$ 10,488,000
Restricted cash	2,825,000	2,673,000
Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows	$ 14,914,000	$ 13,161,000	$ 19,999,000	$ 17,591,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reclassification of Intangible Lease Assets (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Summary of Significant Accounting Policies
Real estate properties, net	$ 174,683,000	$ 179,102,000
Intangible lease assets, net	13,950,000	14,687,000
Other assets, net	1,683,000	422,000
Total assets	$ 217,945,000	219,126,000
As previously reported
Summary of Significant Accounting Policies
Real estate properties, net		192,862,000
Other assets, net		1,349,000
Total assets		219,126,000
Increase (decrease)
Summary of Significant Accounting Policies
Real estate properties, net		(13,760,000)
Intangible lease assets, net		14,687,000
Other assets, net		$ (927,000)

Investments in Real Estate Pr_3

Investments in Real Estate Properties - Investments in real estate properties (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Investments in Real Estate Properties
Real estate properties, net	$ 174,683,000	$ 179,102,000
Land
Investments in Real Estate Properties
Real estate properties, net	15,565,000	15,565,000
Buildings and improvements
Investments in Real Estate Properties
Investments in real estate	166,989,000	166,989,000
Less: accumulated depreciation	(14,840,000)	(11,395,000)
Real estate properties, net	152,149,000	155,594,000
Furniture and fixtures
Investments in Real Estate Properties
Investments in real estate	12,440,000	12,137,000
Less: accumulated depreciation	(5,471,000)	(4,194,000)
Real estate properties, net	$ 6,969,000	$ 7,943,000

Investments in Real Estate Pr_4

Investments in Real Estate Properties - Summary information regarding portfolio (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Investments in Real Estate Properties
Purchase Price	$ 207,320,000
Loans Payable, Excluding Debt Issuance Costs	$ 171,297,000
Sheridan Care Center
Investments in Real Estate Properties
Location	Sheridan, OR
Date Purchased	Aug. 03, 2012
Type	SNF
Purchase Price	$ 4,100,000
Loans Payable, Excluding Debt Issuance Costs	$ 4,044,000
Fernhill Care Center
Investments in Real Estate Properties
Location	Portland, OR
Date Purchased	Aug. 03, 2012
Type	SNF
Purchase Price	$ 4,500,000
Loans Payable, Excluding Debt Issuance Costs	$ 3,548,000
Friendship Haven Healthcare and Rehabilitation Center
Investments in Real Estate Properties
Location	Galveston County, TX
Date Purchased	Sep. 14, 2012
Type	SNF
Purchase Price	$ 15,000,000
Loans Payable, Excluding Debt Issuance Costs	$ 11,381,000
Pacific Health and Rehabilitation Center
Investments in Real Estate Properties
Location	Tigard, OR
Date Purchased	Dec. 24, 2012
Type	SNF
Purchase Price	$ 8,140,000
Loans Payable, Excluding Debt Issuance Costs	$ 5,915,000
Brookstone of Aledo
Investments in Real Estate Properties
Location	Aledo, IL
Date Purchased	Jul. 02, 2013
Type	AL
Purchase Price	$ 8,625,000
Loans Payable, Excluding Debt Issuance Costs	$ 6,633,000
Sundial Assisted Living
Investments in Real Estate Properties
Location	Redding, CA
Date Purchased	Dec. 18, 2013
Type	AL
Purchase Price	$ 3,500,000
Loans Payable, Excluding Debt Issuance Costs	$ 3,698,000
Pennington Gardens
Investments in Real Estate Properties
Location	Chandler, AZ
Date Purchased	Jul. 17, 2017
Type	AL/MC
Purchase Price	$ 13,400,000
Loans Payable, Excluding Debt Issuance Costs	$ 10,078,000
Yucaipa Hill Post Acute
Investments in Real Estate Properties
Location	Yucaipa, CA
Date Purchased	Jul. 02, 2021
Type	SNF
Purchase Price	$ 10,715,000
Loans Payable, Excluding Debt Issuance Costs	$ 8,014,000
Creekside Post Acute
Investments in Real Estate Properties
Location	Yucaipa, CA
Date Purchased	Jul. 02, 2021
Type	SNF
Purchase Price	$ 4,780,000
Loans Payable, Excluding Debt Issuance Costs	$ 3,575,000
University Post Acute
Investments in Real Estate Properties
Location	Mentone, CA
Date Purchased	Jul. 02, 2021
Type	SNF
Purchase Price	$ 4,560,000
Loans Payable, Excluding Debt Issuance Costs	$ 3,411,000
Calhoun Health Center
Investments in Real Estate Properties
Location	Calhoun, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 7,670,000
Loans Payable, Excluding Debt Issuance Costs	$ 6,549,000
Maple Ridge Health Care Center
Investments in Real Estate Properties
Location	Cartersville, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 13,548,000
Loans Payable, Excluding Debt Issuance Costs	$ 11,568,000
Chatsworth Health Care Center
Investments in Real Estate Properties
Location	Chatsworth, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 29,785,000
Loans Payable, Excluding Debt Issuance Costs	$ 25,432,000
East Lake Arbor
Investments in Real Estate Properties
Location	Decatur, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 15,640,000
Loans Payable, Excluding Debt Issuance Costs	$ 13,354,000
Fairburn Health Care Center
Investments in Real Estate Properties
Location	Fairburn, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 14,644,000
Loans Payable, Excluding Debt Issuance Costs	$ 12,503,000
Grandview Health Care Center
Investments in Real Estate Properties
Location	Jasper, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 10,061,000
Loans Payable, Excluding Debt Issuance Costs	$ 8,591,000
Rosemont at Stone Mountain
Investments in Real Estate Properties
Location	Stone Mountain, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 23,908,000
Loans Payable, Excluding Debt Issuance Costs	$ 20,414,000
Willowwood Nursing Center & Rehab
Investments in Real Estate Properties
Location	Flowery Branch, GA
Date Purchased	Dec. 30, 2021
Type	SNF
Purchase Price	$ 14,744,000
Loans Payable, Excluding Debt Issuance Costs	$ 12,589,000

Investments in Real Estate Pr_5

Investments in Real Estate Properties - Future Minimum Lease Payments (Details)	Sep. 30, 2022 USD ($)
Investments in Real Estate Properties
October 1, 2022 to December 31, 2022	$ 4,433,000
2023	17,983,000
2024	18,272,000
2025	18,566,000
2026	18,865,000
Thereafter	165,462,000
Future minimum lease payments	$ 243,581,000

Investments in Real Estate Pr_6

Investments in Real Estate Properties (Details)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Feb. 10, 2022 USD ($)

Dec. 30, 2021 USD ($) facility

Jul. 02, 2021 USD ($) facility item

May 31, 2021 USD ($)

Mar. 31, 2021 USD ($)

Sep. 30, 2022 USD ($)

Sep. 30, 2021 USD ($) property

Sep. 30, 2022 USD ($)

Sep. 30, 2021 USD ($) property

Dec. 31, 2021 USD ($)

Sep. 30, 2022

Sep. 30, 2022 property

Investments in Real Estate Properties

Number of leased real estate properties

10

10

18

16

Depreciation and amortization

$ 1,600,000

$ 500,000

$ 4,800,000

$ 1,300,000

Equity-method investments

7,640,000

$ 7,640,000

$ 7,902,000

Percentage of Real Estate Properties

100%

Unamortized balance of capitalized leasing commissions

$ 400,000

$ 500,000

Amortization of Deferred Leasing Commissions

15,000

$ 18,000

63,000

$ 53,000

Principal amount of loan

$ 12,750,000

CA3 Properties

Investments in Real Estate Properties

Acquisition costs

$ 80,000

Number of skilled nursing facilities acquired | facility

3

Purchase price amount

$ 20,055,000

Number of unrelated parties for lease under acquisition | item

3

Lease term under three separate triple net leases

15 years

CA3 Properties | First renewal options

Investments in Real Estate Properties

Lease renewal options

5 years

CA3 Properties | Second renewal options

Investments in Real Estate Properties

Lease renewal options

5 years

CA3 Properties | Yucaipa, California

Investments in Real Estate Properties

Number of skilled nursing facilities acquired | facility

2

CA3 Properties | Mentone, California

Investments in Real Estate Properties

Number of skilled nursing facilities acquired | facility

1

GA8 Properties

Investments in Real Estate Properties

Number of skilled nursing facilities acquired | facility

8

Purchase price amount

$ 130,000,000

Lease term under three separate triple net leases

15 years

GA8 Properties | First renewal options

Investments in Real Estate Properties

Lease renewal options

5 years

GA8 Properties | Second renewal options

Investments in Real Estate Properties

Lease renewal options

5 years

Pennington Gardens facility in Chandler, Arizona

Investments in Real Estate Properties

Rent receivable written off

$ 400,000

Rent proceeds received, Settlement

$ 200,000

Sundial Assisted Living facility in Redding, California

Investments in Real Estate Properties

Rent receivable written off

$ 100,000

Rent proceeds received, Settlement

50,000

Summit Georgia Holdings LLC

Investments in Real Estate Properties

Number of leased real estate properties | property

35

Principal amount of loan

$ 12,750,000

$ 12,750,000

Pennington Gardens and Sundial Operations LLC

Investments in Real Estate Properties

Percentage of Real Estate Properties

100%

Loans Payable - Debt (Details)

Loans Payable - Debt (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Loans Payable
Long-term debt, gross	$ 184,047,000	$ 184,878,000
Less debt issuance costs	(3,824,000)	(4,508,000)
Total loans payable	180,223,000	180,370,000
Lument Capital (formerly ORIX Real Estate Capital, LLC)
Loans Payable
Long-term debt, gross	35,219,000	35,934,000
Capital One Multifamily Finance LLC
Loans Payable
Long-term debt, gross	10,078,000	10,194,000
CIBC Bank | LIBOR
Loans Payable
Long-term debt, gross	15,000,000	15,000,000
CIBC Bank | SOFR
Loans Payable
Long-term debt, gross	91,000,000	91,000,000
Oxford Finance, LLC | LIBOR
Loans Payable
Long-term debt, gross	20,000,000	20,000,000
Oxford Finance, LLC | GA8 Properties
Loans Payable
Long-term debt, gross	$ 12,750,000	$ 12,750,000

Loans Payable - (Parenthetical)

Loans Payable - (Parenthetical) (Details) - USD ($)		9 Months Ended	12 Months Ended
	Jul. 02, 2021	Sep. 30, 2022	Dec. 31, 2021	Dec. 30, 2021
Loans Payable
Stated Percentage on interest rate				11%
Principal amount of loan				$ 12,750,000
Lument Capital (formerly ORIX Real Estate Capital, LLC)
Loans Payable
Debt Instrument, Periodic Payment		$ 183,000	$ 183,000
Lument Capital (formerly ORIX Real Estate Capital, LLC) | Minimum
Loans Payable
Stated Percentage on interest rate		2.79%	2.79%
Lument Capital (formerly ORIX Real Estate Capital, LLC) | Maximum
Loans Payable
Stated Percentage on interest rate		4.20%	4.20%
Capital One Multifamily Finance LLC
Loans Payable
Debt Instrument, Periodic Payment		$ 49,000	$ 49,000
Stated Percentage on interest rate		4.23%	4.23%
CIBC Bank | SOFR
Loans Payable
Debt Instrument, Periodic Payment		$ 459,000	$ 459,000
Variable interest rate		6.10%	4%
CIBC Bank | CA3 Properties
Loans Payable
Debt Instrument, Periodic Payment		$ 106,000	$ 106,000
Principal amount of loan	$ 15,000,000
LIBOR floor (as a percentage)	4%
Variable interest rate	1%	6.63%	5%
Oxford Finance, LLC
Loans Payable
Debt Instrument, Periodic Payment		$ 226,000	$ 226,000
Periodic payment		$ 144,000	$ 144,000
Oxford Finance, LLC | LIBOR
Loans Payable
Variable interest rate		13.60%	12%

Loans Payable - Maturities of l

Loans Payable - Maturities of long term debt (Details)	Sep. 30, 2022 USD ($)
Loans Payable
October 1, 2022 to December 31, 2022	$ 283,000
2023	1,158,000
2024	107,201,000
2025	21,246,000
2026	14,042,000
Thereafter	40,117,000
Total	$ 184,047,000

Loans Payable - Additional info

Loans Payable - Additional information (Details) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 30, 2021	Jul. 02, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2024
Loans Payable
Stated Percentage on interest rate	11%
Loans payable			$ 184,047,000		$ 184,047,000		$ 184,878,000
Interest expense (excluding debt issuance costs amortization and interest expense related to the Oxford mezzanine loan)			3,200,000	$ 700,000	8,400,000	$ 1,700,000
Debt instrument unamortized cost			3,824,000		3,824,000		4,508,000
Amortization of debt issuance costs			200,000	$ 10,000	700,000	$ 10,000
Exit fee of loan								$ 100,000
Monthly interest fee percentage	22%
Description of variable rate	100
Prepayment Premium percentage Prior to First anniversary	5%
Loan paid off after due date							140,000
Interest expense related to Oxford monthly fee			100,000		500,000
Principal amount of loan	$ 12,750,000
GA8 Properties | SOFR
Loans Payable
Stated Percentage on interest rate	0.75%
Description of variable rate	50
Interest on loan with LIBOR	3.50%
GA8 Properties | LIBOR
Loans Payable
Description of variable rate	100
GA8 Properties | Summit Georgia Holdings LLC
Loans Payable
Principal amount of loan			12,750,000		12,750,000
GA8 Properties | Summit Georgia Holdings LLC | Minimum
Loans Payable
Stated Percentage on interest rate	4%
CIBC Bank | SOFR
Loans Payable
Debt Instrument, Periodic Payment					459,000		459,000
Loans payable			91,000,000		$ 91,000,000		$ 91,000,000
Interest on loan with LIBOR					6.10%		4%
CIBC Bank | LIBOR
Loans Payable
Loans payable			15,000,000		$ 15,000,000		$ 15,000,000
CIBC Bank | CA3 Properties
Loans Payable
Debt Instrument, Periodic Payment					$ 106,000		$ 106,000
Interest on loan with LIBOR		1%			6.63%		5%
Principal amount of loan		$ 15,000,000
LIBOR floor (as a percentage)		4%
Percentage of prepayment premium if prepayment occurs on or prior to first year anniversary		3%
Percentage of prepayment premium if prepayment occurs on second year anniversary		2%
Percentage of prepayment premium if prepayment occurs on third year anniversary		1%
Percentage of exit fee if sale or transfer occurs on or prior to second year anniversary		0.50%
Percentage of exit fee if sale or transfer occurs after second year anniversary		0%
CIBC Bank | GA8 Properties
Loans Payable
Debt Instrument, Periodic Payment	$ 91,000,000
Oxford Finance | GA8 Properties
Loans Payable
Debt Instrument, Periodic Payment	$ 20,000,000
Percentage of prepayment premium if prepayment occurs on or prior to first year anniversary	5%
Percentage of prepayment premium if prepayment occurs on second year anniversary	2%
Percentage of prepayment premium if prepayment occurs on third year anniversary	1%
Oxford Finance | GA8 Properties | LIBOR
Loans Payable
Stated Percentage on interest rate	11%
Lument Capital (formerly ORIX Real Estate Capital, LLC)
Loans Payable
Debt Instrument, Periodic Payment					$ 183,000		$ 183,000
Loans payable			$ 35,219,000		$ 35,219,000		$ 35,934,000
Lument Capital (formerly ORIX Real Estate Capital, LLC) | Minimum
Loans Payable
Stated Percentage on interest rate			2.79%		2.79%		2.79%
Lument Capital (formerly ORIX Real Estate Capital, LLC) | Maximum
Loans Payable
Stated Percentage on interest rate			4.20%		4.20%		4.20%
First Priority Mortgage Loan | GA8 Properties
Loans Payable
Principal amount of loan			$ 91,000,000		$ 91,000,000
Percentage of prepayment premium if prepayment occurs on or prior to first year anniversary	3%
Percentage of prepayment premium if prepayment occurs on second year anniversary	2%
Percentage of prepayment premium if prepayment occurs on third year anniversary	1%
Percentage of exit fee if sale or transfer occurs on or prior to second year anniversary	0.50%
Percentage of exit fee if sale or transfer occurs after second year anniversary	0%
Second Priority Mortgage Loan | GA8 Properties
Loans Payable
Principal amount of loan			$ 20,000,000		$ 20,000,000

Equity-Method Investments - Sum

Equity-Method Investments - Summarized Financial Data for Equity-Method Investments (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Equity-Method Investments
Revenue	$ 6,706,000	$ 2,025,000	$ 19,283,000	$ 4,870,000
Income (loss) from operations			7,766,000	6,058,000
Net income (loss)	$ (1,988,000)	(247,000)	(4,507,000)	546,000
Summit interest in Equity-Method Investments net income (loss)			(293,000)	(595,000)
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue			28,802,000	26,679,000
Net income (loss)			3,015,000	(3,324,000)
SUL JV
Equity-Method Investments
Income (loss) from operations			4,484,000	5,072,000
Summit interest in Equity-Method Investments net income (loss)			91,000	142,000
SUL JV | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue			15,670,000	15,339,000
Net income (loss)			910,000	1,421,000
Fantasia JV
Equity-Method Investments
Income (loss) from operations			(2,480,000)	282,000
Summit interest in Equity-Method Investments net income (loss)			(942,000)	129,000
Additional impairment charges			203,000
Fantasia JV | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue			1,962,000	2,860,000
Net income (loss)			(2,692,000)	369,000
Fantasia II JV
Equity-Method Investments
Income (loss) from operations			1,484,000	1,448,000
Summit interest in Equity-Method Investments net income (loss)			158,000	148,000
Fantasia II JV | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue			2,147,000	2,759,000
Net income (loss)			791,000	738,000
Fantasia III JV
Equity-Method Investments
Income (loss) from operations			3,026,000	3,094,000
Summit interest in Equity-Method Investments net income (loss)			137,000	151,000
Fantasia III JV | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue			6,250,000	6,156,000
Net income (loss)			1,373,000	1,510,000
FPH JV
Equity-Method Investments
Income (loss) from operations			1,252,000	1,255,000
Summit interest in Equity-Method Investments net income (loss)			263,000	121,000
FPH JV | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue			2,773,000	2,731,000
Net income (loss)			$ 2,633,000	1,205,000
Indiana JV
Equity-Method Investments
Income (loss) from operations				(5,093,000)
Summit interest in Equity-Method Investments net income (loss)				$ (1,286,000)
Indiana JV | Above-market leases
Equity-Method Investments
Revenue interest rate				15%
Accumulated Amortization		$ 1,500,000		$ 1,500,000
Interest income				400,000
Indiana JV | Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity-Method Investments
Revenue				(3,166,000)
Net income (loss)				$ (8,567,000)

Equity-Method Investments - Dis

Equity-Method Investments - Distributions receivable (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Equity-Method Investments
Distributions receivable	$ 635,000	$ 582,000
SUL JV
Equity-Method Investments
Distributions receivable	260,000	273,000
Fantasia JV
Equity-Method Investments
Distributions receivable	235,000	205,000
Fantasia II JV
Equity-Method Investments
Distributions receivable	49,000	54,000
Fantasia III JV
Equity-Method Investments
Distributions receivable	27,000	22,000
FPH JV
Equity-Method Investments
Distributions receivable	$ 64,000	$ 28,000

Equity-Method Investments - Cas

Equity-Method Investments - Cash Distributions (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Equity-Method Investments
Total Cash Distributions Received	$ 822,000	$ 1,866,000
Cash Flow from Operating Activities	400,000	527,000
Cash Flow from Investing Activities	422,000	1,339,000
SUL JV
Equity-Method Investments
Total Cash Distributions Received	434,000	631,000
Cash Flow from Operating Activities	91,000	142,000
Cash Flow from Investing Activities	343,000	489,000
Fantasia JV
Equity-Method Investments
Total Cash Distributions Received	0	0
Cash Flow from Operating Activities	0	0
Cash Flow from Investing Activities	0	0
Fantasia II JV
Equity-Method Investments
Total Cash Distributions Received	237,000	225,000
Cash Flow from Operating Activities	158,000	148,000
Cash Flow from Investing Activities	79,000	77,000
Fantasia III JV
Equity-Method Investments
Total Cash Distributions Received	95,000	123,000
Cash Flow from Operating Activities	95,000	123,000
Cash Flow from Investing Activities	0	0
FPH JV
Equity-Method Investments
Total Cash Distributions Received	56,000	114,000
Cash Flow from Operating Activities	56,000	114,000
Cash Flow from Investing Activities	0	0
Indiana JV
Equity-Method Investments
Total Cash Distributions Received	0	773,000
Cash Flow from Operating Activities	0	0
Cash Flow from Investing Activities	$ 0	$ 773,000

Equity-Method Investments - Add

Equity-Method Investments - Additional information (Details)	1 Months Ended				3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Aug. 31, 2022 property	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Equity-Method Investments
Equity-method investment	$ 7,640,000				$ 7,640,000		$ 7,640,000		$ 7,902,000
Indiana JV
Equity-Method Investments
Equity-method investment				$ 5,400,000
Limited partnership interest				15%
Indiana JV | Indiana JV
Equity-Method Investments
Equity method investment ownership percentage	0%				0%		0%		0%
SUL JV.
Equity-Method Investments
Invested to capital calls							$ 821,000
Fantasia JV.
Equity-Method Investments
Invested to capital calls							290,000
Number of properties agreed to sale | property		1
Impairment charge							$ 1,100,000
Equity method investment ownership percentage	35%				35%		35%
Impairment charges for fair value of investments impaired	$ 100,000		$ 100,000
Indiana JV
Equity-Method Investments
Invested to capital calls							$ 5,400,000
Equity Method Investments
Equity-Method Investments
Asset management fees					$ 200,000	$ 200,000	$ 500,000	$ 800,000
Summit Union Life Holdings, LLC
Equity-Method Investments
Minimum percentage of interest in annual return							9%
Percentage of interest in annual return							10%
Equity-method investment	3,300,000				3,300,000		$ 3,300,000		$ 2,900,000
Summit Union Life Holdings, LLC | Operating Partnership
Equity-Method Investments
Percentage of Interest							25%
Percentage of interest in capital proceeds from the sale of properties held							25%
Summit Union Life Holdings, LLC | Best Years Llc
Equity-Method Investments
Percentage of Interest							75%
Percentage of interest in capital proceeds from the sale of properties held							75%
Summit Fantasia Holdings Llc
Equity-Method Investments
Percentage of interest in annual return							8%
Equity-method investment	1,100,000				1,100,000		$ 1,100,000		2,000,000
Summit Fantasia Holdings Llc | Operating Partnership
Equity-Method Investments
Percentage of Interest							50%
Percentage of interest in capital proceeds from the sale of properties held							50%
Summit Fantasia Holdings Llc | Fantasia JV.
Equity-Method Investments
Impairment charge			$ 3,200,000
Summit Fantasia Holdings Llc | Fantasia Investment III LLC
Equity-Method Investments
Percentage of Interest							50%
Percentage of interest in capital proceeds from the sale of properties held							50%
Summit Fantasia ll Holdings LLC
Equity-Method Investments
Percentage of interest in annual return							8%
Equity-method investment	1,200,000				1,200,000		$ 1,200,000		1,300,000
Summit Fantasia ll Holdings LLC | Operating Partnership
Equity-Method Investments
Percentage of Interest							30%
Percentage of interest in capital proceeds from the sale of properties held							30%
Summit Fantasia ll Holdings LLC | Fantasia Investment III LLC
Equity-Method Investments
Percentage of Interest							70%
Percentage of interest in capital proceeds from the sale of properties held							70%
Summit Fantasia Holdings III, LLC
Equity-Method Investments
Percentage of interest in annual return							9%
Equity-method investment	1,600,000				1,600,000		$ 1,600,000		1,500,000
Summit Fantasia Holdings III, LLC | Operating Partnership
Equity-Method Investments
Percentage of Interest							25%
Percentage of interest in capital proceeds from the sale of properties held							25%
Summit Fantasia Holdings III, LLC | Fantasia Investment III LLC
Equity-Method Investments
Percentage of Interest							75%
Percentage of interest in capital proceeds from the sale of properties held							75%
Summit Fantasy Pearl Holdings, LLC
Equity-Method Investments
Percentage of interest in annual return							9%
Equity-method investment	$ 400,000				$ 400,000		$ 400,000		$ 200,000
Summit Fantasy Pearl Holdings, LLC | Operating Partnership
Equity-Method Investments
Percentage of Interest							20%
Percentage of interest in capital proceeds from the sale of properties held							20%
Summit Fantasy Pearl Holdings, LLC | Fantasia Investment III LLC
Equity-Method Investments
Percentage of Interest							7.25%
Percentage of interest in capital proceeds from the sale of properties held							7.25%
Summit Fantasy Pearl Holdings, LLC | Summit Fantasy Pearl Holdings, LLC- Equity-Method Investment
Equity-Method Investments
Percentage of Interest							65.25%
Percentage of interest in capital proceeds from the sale of properties held							65.25%
Summit Fantasy Pearl Holdings, LLC | Atlantis
Equity-Method Investments
Percentage of Interest							7.50%
Percentage of interest in capital proceeds from the sale of properties held							7.50%

Receivables (Details)

Receivables (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Receivables
Straight-line rent receivables	$ 3,503,000	$ 2,395,000
Distribution receivables from Equity-Method Investments	635,000	582,000
Asset management fees	303,000	323,000
Other receivables	232,000	86,000
Total	$ 4,673,000	$ 3,386,000

Intangible Lease Assets (Detail

Intangible Lease Assets (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Intangible Lease Assets
Intangible lease assets, net	$ 13,950,000		$ 13,950,000		$ 14,687,000
In-place leases
Intangible Lease Assets
Intangible lease assets, gross	13,778,000		13,778,000		13,778,000
Less: accumulated amortization	(707,000)		(707,000)		(18,000)
Intangible lease assets, net	13,071,000		13,071,000		13,760,000
In-place leases | Rental revenues
Intangible Lease Assets
Amortization expense for intangible lease assets	200,000	$ 25,000	700,000	$ 25,000
Above-market leases
Intangible Lease Assets
Intangible lease assets, gross	959,000		959,000		959,000
Less: accumulated amortization	(80,000)		(80,000)		(32,000)
Intangible lease assets, net	879,000		879,000		$ 927,000
Above-market leases | Rental revenues
Intangible Lease Assets
Amortization of above market leases	$ 16,000	$ 16,000	$ 48,000	$ 16,000

Intangible Lease Assets - Expec

Intangible Lease Assets - Expected future amortization (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Intangible Lease Assets
October 1, 2022 to December 31, 2022	$ 244,000
2023	980,000
2024	980,000
2025	980,000
2026	980,000
Thereafter	9,786,000
Intangible lease assets, net	$ 13,950,000	$ 14,687,000

Right of Use (ROU) Asset - Op_3

Right of Use (ROU) Asset - Operating (Details) - USD ($)		1 Months Ended
	Apr. 01, 2022	Nov. 30, 2022	Sep. 30, 2022
Lease
Estimated incremental borrowing rate	5%
Right of use asset - operating	$ 888,000
Lease liability - operating	$ 888,000		$ 907,000
Operating lease, weighted average remaining lease term			5 years 7 months 6 days
Temporary License
Lease
Termination term of lease after substantial completion of certain tenant improvements in office space	5 years
Standard Office Lease
Lease
Lease term under three separate triple net leases		66 months
Lease renewal options		5 years
Initial annual base rent		$ 204,399
Increase in initial annual base rent (as a percent)		3%

Right of Use (ROU) Asset - Op_4

Right of Use (ROU) Asset - Operating Income (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Apr. 01, 2022
Lease
Right of use asset - operating			$ 888,000
Lease liability - operating	$ 907,000	$ 907,000	$ 888,000
Operating lease expense	30,000	50,000
LH Lease
Lease
Right of use asset - operating	$ 856,000	$ 856,000
Right of use asset - operating, Location	Other Assets	Other Assets
Lease liability - operating	$ 907,000	$ 907,000
Lease liability, location	Accounts Payable and Accrued Liabilities	Accounts Payable and Accrued Liabilities

Right of Use (ROU) Asset - Op_5

Right of Use (ROU) Asset - Operating Expenses (Details) - USD ($)	Sep. 30, 2022	Apr. 01, 2022
Maturity of lease payments
October 1, 2022 to December 31, 2022	$ 17,000
2023	120,000
2024	212,000
2025	218,000
2026	224,000
Thereafter	310,000
Total lease payments	1,101,000
Less imputed interest ($155,000) and moving expense reimbursement ($39,000)	(194,000)
Total lease liability	907,000	$ 888,000
Imputed interest	155,000
Moving expense reimbursement	$ 39,000

Concentration of Risk (Details)

Concentration of Risk (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022 tenant	Sep. 30, 2021 property tenant	Sep. 30, 2022 tenant	Sep. 30, 2021 property tenant	Sep. 30, 2022 property
Concentration of Risk
Number of owned properties held by equity method investment					35
Number of leased real estate properties	18	10	18	10	16
Number of tenants under long-term triple net leases | tenant	14	8	14	8
Number of tenants represents more than 10% of our rental revenue | tenant	3	4	3	3
Customer Concentration Risk | Tenant | Assets, Total
Concentration of Risk
Concentration risk, percentage			20%
Customer Concentration Risk | Tenant One | Tenant One, Concentration Risk
Concentration of Risk
Concentration risk, percentage	10%	10%	10%	10%
Georgia
Concentration of Risk
Number of owned properties					8
California
Concentration of Risk
Number of owned properties					4
Oregon
Concentration of Risk
Number of owned properties					3
Texas
Concentration of Risk
Number of owned properties					1
Illinois
Concentration of Risk
Number of owned properties					1
Arizona
Concentration of Risk
Number of owned properties					1

Fair Value Measurements of Fi_2

Fair Value Measurements of Financial Instruments (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fair Value Measurements of Financial Instruments
Long-term debt, gross	$ 184,047,000		$ 184,047,000		$ 184,878,000
Asset impairment charges	0	$ 0	0	$ 0
HUD
Fair Value Measurements of Financial Instruments
Fair value of loans payable	35,600,000		35,600,000		52,500,000
Long-term debt, gross	$ 45,300,000		$ 45,300,000		$ 46,100,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Commitments and Contingencies
Purchased the investors' interests	$ 0.9

Equity - Estimated fair value u

Equity - Estimated fair value using the Black-Scholes option-pricing model (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Equity
Stock options granted | shares	81,000
Expected volatility	36.50%
Expected term	5 years 9 months
Risk-free interest rate	2.53%
Dividend yield	0%
Fair value per share | $ / shares	$ 0.91

Equity - Stock options (Details

Equity - Stock options (Details)	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares
Equity
Options outstanding, Beginning Balance	1,867,908
Options outstanding, Granted	81,000
Options outstanding, Exercised	0
Options outstanding, Ending Balance	1,948,908
Options exercisable, Ending Balance	1,874,380
Weighted Average Exercise Price, Outstanding at Beginning Balance | $ / shares	$ 2.09
Weighted Average Exercise Price, Granted | $ / shares	2.35
Weighted Average Exercise Price, Outstanding at Ending Balance | $ / shares	2.10
Weighted Average Exercise Price, Exercisable at Ending Balance | $ / shares	$ 2.09
Options outstanding, Weighted Average Remaining Contractual Term	5 years 2 months 26 days
Options exercisable, Weighted Average Remaining Contractual Term	5 years 29 days
Options outstanding, Aggregate Intrinsic Value | $	$ 1,644,000
Options exercisable, Aggregate Intrinsic Value | $	$ 1,600,000

Equity - Additional Information

Equity - Additional Information (Details) - USD ($)		3 Months Ended		9 Months Ended
	Apr. 01, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Equity
Options outstanding, Granted				81,000
Fair value per stock option				$ 0.91
Weighted average grant date fair value (per share)		$ 0.89		$ 0.89
General and Administrative Expense.
Equity
Stock-based compensation expense		$ 9,000	$ 9,000	$ 23,000	$ 56,000
Director
Equity
Options outstanding, Granted	81,000

Equity - Unrecognized stock-bas

Equity - Unrecognized stock-based compensation expense (Details)	Sep. 30, 2022 USD ($)
Schedule of equity method investments
Unrecognized stock-based compensation expense related to unvested stock options, net of forfeitures	$ 66,000
October 1, 2022 to December 31, 2022
Schedule of equity method investments
Unrecognized stock-based compensation expense related to unvested stock options, net of forfeitures	8,000
2023
Schedule of equity method investments
Unrecognized stock-based compensation expense related to unvested stock options, net of forfeitures	25,000
2024
Schedule of equity method investments
Unrecognized stock-based compensation expense related to unvested stock options, net of forfeitures	25,000
2025
Schedule of equity method investments
Unrecognized stock-based compensation expense related to unvested stock options, net of forfeitures	$ 8,000

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
(Loss) income	$ (1,976,000)	$ (229,000)	$ (4,458,000)	$ 604,000
(Income) loss attributable to noncontrolling interest	(12,000)	(18,000)	(49,000)	(58,000)
Net (loss) income applicable to common stockholders	$ (1,988,000)	$ (247,000)	$ (4,507,000)	$ 546,000
Basic:
Denominator for basic EPS - weighted average shares	23,027,978	23,027,978	23,027,978	23,027,978
Effect of dilutive shares:
Stock options				525,628
Denominator for diluted EPS - adjusted weighted average shares	23,027,978	23,027,978	23,027,978	23,553,606
Basic EPS	$ (0.09)	$ (0.01)	$ (0.20)	$ 0.02
Diluted EPS	$ (0.09)	$ (0.01)	$ (0.20)	$ 0.02
Number of stock options to purchase	559,275	525,628	559,275